ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0001503,ossification, 18/19,429/18614,4.40E-29,5.46E-26,3.02E-26,HNRNPU/GTPBP4/RBMX/SNRNP200/RPL38/SYNCRIP/MYBBP1A/SIRT7/DHX9/SFRP1/HIF1A/AXIN2/DDX21/IGFBP3/IFITM1/ADAR/FBL/ALYREF,18
GO:0001649,osteoblast differentiation, 16/19,250/18614,6.46E-28,4.01E-25,2.22E-25,HNRNPU/GTPBP4/RBMX/SNRNP200/SYNCRIP/MYBBP1A/SIRT7/DHX9/SFRP1/AXIN2/DDX21/IGFBP3/IFITM1/ADAR/FBL/ALYREF,16
GO:0022613,ribonucleoprotein complex biogenesis, 9/19,475/18614,3.13E-10,1.30E-07,7.17E-08,GTPBP4/SNRNP200/RPL38/MYBBP1A/SIRT7/DHX9/DDX21/ADAR/FBL,9
GO:1903312,negative regulation of mRNA metabolic process, 5/19,96/18614,3.61E-08,1.12E-05,6.19E-06,HNRNPU/RBMX/SYNCRIP/DHX9/AXIN2,5
GO:0070934,CRD-mediated mRNA stabilization, 3/19,11/18614,1.48E-07,3.68E-05,2.03E-05,HNRNPU/SYNCRIP/DHX9,3
GO:1900152,"negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay", 3/19,12/18614,1.97E-07,4.08E-05,2.26E-05,HNRNPU/SYNCRIP/DHX9,3
GO:0042254,ribosome biogenesis, 6/19,298/18614,3.65E-07,5.52E-05,3.05E-05,GTPBP4/RPL38/MYBBP1A/SIRT7/DDX21/FBL,6
GO:0006397,mRNA processing, 7/19,500/18614,3.68E-07,5.52E-05,3.05E-05,HNRNPU/RBMX/SNRNP200/SYNCRIP/DHX9/ADAR/ALYREF,7
GO:2000767,positive regulation of cytoplasmic translation, 3/19,15/18614,4.07E-07,5.52E-05,3.05E-05,HNRNPU/SYNCRIP/DHX9,3
GO:0048255,mRNA stabilization, 4/19,63/18614,4.44E-07,5.52E-05,3.05E-05,HNRNPU/SYNCRIP/DHX9/AXIN2,4
GO:0000377,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile", 6/19,325/18614,6.06E-07,6.22E-05,3.44E-05,HNRNPU/RBMX/SNRNP200/SYNCRIP/DHX9/ALYREF,6
GO:0000398,"mRNA splicing, via spliceosome", 6/19,325/18614,6.06E-07,6.22E-05,3.44E-05,HNRNPU/RBMX/SNRNP200/SYNCRIP/DHX9/ALYREF,6
GO:0000375,"RNA splicing, via transesterification reactions", 6/19,329/18614,6.51E-07,6.22E-05,3.44E-05,HNRNPU/RBMX/SNRNP200/SYNCRIP/DHX9/ALYREF,6
GO:0043489,RNA stabilization, 4/19,72/18614,7.63E-07,6.68E-05,3.69E-05,HNRNPU/SYNCRIP/DHX9/AXIN2,4
GO:1902373,negative regulation of mRNA catabolic process, 4/19,73/18614,8.07E-07,6.68E-05,3.69E-05,HNRNPU/SYNCRIP/DHX9/AXIN2,4
GO:1902369,negative regulation of RNA catabolic process, 4/19,85/18614,1.49E-06,1.16E-04,6.39E-05,HNRNPU/SYNCRIP/DHX9/AXIN2,4
GO:1900151,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay", 3/19,26/18614,2.31E-06,1.69E-04,9.32E-05,HNRNPU/SYNCRIP/DHX9,3
GO:2000765,regulation of cytoplasmic translation, 3/19,29/18614,3.24E-06,2.24E-04,1.24E-04,HNRNPU/SYNCRIP/DHX9,3
GO:0008380,RNA splicing, 6/19,466/18614,4.90E-06,3.21E-04,1.77E-04,HNRNPU/RBMX/SNRNP200/SYNCRIP/DHX9/ALYREF,6
GO:0045943,positive regulation of transcription by RNA polymerase I, 3/19,35/18614,5.78E-06,3.59E-04,1.98E-04,MYBBP1A/SIRT7/DDX21,3
GO:0006356,regulation of transcription by RNA polymerase I, 3/19,46/18614,1.33E-05,7.87E-04,4.35E-04,MYBBP1A/SIRT7/DDX21,3
GO:1903311,regulation of mRNA metabolic process, 5/19,329/18614,1.59E-05,8.96E-04,4.95E-04,HNRNPU/RBMX/SYNCRIP/DHX9/AXIN2,5
GO:0002181,cytoplasmic translation, 4/19,159/18614,1.80E-05,9.71E-04,5.36E-04,HNRNPU/RPL38/SYNCRIP/DHX9,4
GO:1903313,positive regulation of mRNA metabolic process, 4/19,166/18614,2.13E-05,0.001102183,6.09E-04,HNRNPU/RBMX/SYNCRIP/DHX9,4
GO:0006360,transcription by RNA polymerase I, 3/19,64/18614,3.61E-05,0.001794244,9.91E-04,MYBBP1A/SIRT7/DDX21,3
GO:0043488,regulation of mRNA stability, 4/19,195/18614,4.00E-05,0.001907679,0.001054163,HNRNPU/SYNCRIP/DHX9/AXIN2,4
GO:0006403,RNA localization, 4/19,197/18614,4.16E-05,0.001907679,0.001054163,HNRNPU/DHX9/FBL/ALYREF,4
GO:0000288,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay", 3/19,68/18614,4.33E-05,0.001907679,0.001054163,HNRNPU/SYNCRIP/DHX9,3
GO:0009615,response to virus, 5/19,408/18614,4.45E-05,0.001907679,0.001054163,DHX9/HIF1A/DDX21/IFITM1/ADAR,5
GO:0045600,positive regulation of fat cell differentiation, 3/19,71/18614,4.93E-05,0.001996216,0.001103087,HNRNPU/SFRP1/AXIN2,3
GO:0043487,regulation of RNA stability, 4/19,207/18614,5.05E-05,0.001996216,0.001103087,HNRNPU/SYNCRIP/DHX9/AXIN2,4
GO:0000380,"alternative mRNA splicing, via spliceosome", 3/19,72/18614,5.14E-05,0.001996216,0.001103087,HNRNPU/RBMX/DHX9,3
GO:0061013,regulation of mRNA catabolic process, 4/19,212/18614,5.54E-05,0.002086335,0.001152886,HNRNPU/SYNCRIP/DHX9/AXIN2,4
GO:0034470,ncRNA processing, 5/19,432/18614,5.85E-05,0.002135632,0.001180127,GTPBP4/SIRT7/DDX21/ADAR/FBL,5
GO:0006364,rRNA processing, 4/19,218/18614,6.18E-05,0.002192641,0.00121163,GTPBP4/SIRT7/DDX21/FBL,4
GO:0009950,dorsal/ventral axis specification, 2/19,12/18614,6.48E-05,0.002234026,0.001234498,SFRP1/AXIN2,2
GO:0031331,positive regulation of cellular catabolic process, 5/19,450/18614,7.10E-05,0.002381721,0.001316114,HNRNPU/SYNCRIP/DHX9/HIF1A/AXIN2,5
GO:0022618,ribonucleoprotein complex assembly, 4/19,231/18614,7.74E-05,0.002528705,0.001397335,SNRNP200/RPL38/DHX9/ADAR,4
GO:0071826,ribonucleoprotein complex subunit organization, 4/19,239/18614,8.83E-05,0.002811204,0.001553441,SNRNP200/RPL38/DHX9/ADAR,4
GO:0033689,negative regulation of osteoblast proliferation, 2/19,15/18614,1.03E-04,0.003192881,0.001764352,SFRP1/AXIN2,2
GO:0031330,negative regulation of cellular catabolic process, 4/19,251/18614,1.07E-04,0.003231672,0.001785787,HNRNPU/SYNCRIP/DHX9/AXIN2,4
GO:0016072,rRNA metabolic process, 4/19,257/18614,1.17E-04,0.003455859,0.00190967,GTPBP4/SIRT7/DDX21/FBL,4
GO:0006402,mRNA catabolic process, 4/19,268/18614,1.37E-04,0.003967057,0.002192153,HNRNPU/SYNCRIP/DHX9/AXIN2,4
GO:0035455,response to interferon-alpha, 2/19,18/18614,1.50E-04,0.004127995,0.002281085,IFITM1/ADAR,2
GO:0045945,positive regulation of transcription by RNA polymerase III, 2/19,18/18614,1.50E-04,0.004127995,0.002281085,MYBBP1A/DDX21,2
GO:0097709,connective tissue replacement, 2/19,20/18614,1.86E-04,0.004929341,0.002723901,RUNX1/HIF1A,2
GO:0071347,cellular response to interleukin-1, 3/19,111/18614,1.87E-04,0.004929341,0.002723901,RBMX/SFRP1/HIF1A,3
GO:0051607,defense response to virus, 4/19,303/18614,2.20E-04,0.005645778,0.003119796,DHX9/DDX21/IFITM1/ADAR,4
GO:0140546,defense response to symbiont, 4/19,304/18614,2.23E-04,0.005645778,0.003119796,DHX9/DDX21/IFITM1/ADAR,4
GO:0072089,stem cell proliferation, 3/19,121/18614,2.41E-04,0.005977055,0.003302856,HNRNPU/RUNX1/AXIN2,3
GO:0061157,mRNA destabilization, 3/19,123/18614,2.53E-04,0.006149837,0.003398334,HNRNPU/SYNCRIP/DHX9,3
GO:0006401,RNA catabolic process, 4/19,319/18614,2.68E-04,0.006265918,0.003462479,HNRNPU/SYNCRIP/DHX9/AXIN2,4
GO:0000956,nuclear-transcribed mRNA catabolic process, 3/19,126/18614,2.71E-04,0.006265918,0.003462479,HNRNPU/SYNCRIP/DHX9,3
GO:0050779,RNA destabilization, 3/19,127/18614,2.77E-04,0.006265918,0.003462479,HNRNPU/SYNCRIP/DHX9,3
GO:0061014,positive regulation of mRNA catabolic process, 3/19,127/18614,2.77E-04,0.006265918,0.003462479,HNRNPU/SYNCRIP/DHX9,3
GO:0009895,negative regulation of catabolic process, 4/19,337/18614,3.30E-04,0.007316593,0.00404307,HNRNPU/SYNCRIP/DHX9/AXIN2,4
GO:0050684,regulation of mRNA processing, 3/19,139/18614,3.62E-04,0.007882095,0.004355561,HNRNPU/RBMX/DHX9,3
GO:0045727,positive regulation of translation, 3/19,141/18614,3.77E-04,0.007940573,0.004387875,HNRNPU/SYNCRIP/DHX9,3
GO:0070555,response to interleukin-1, 3/19,141/18614,3.77E-04,0.007940573,0.004387875,RBMX/SFRP1/HIF1A,3
GO:0044342,type B pancreatic cell proliferation, 2/19,29/18614,3.94E-04,0.008160699,0.004509514,SFRP1/IGFBP3,2
GO:0045598,regulation of fat cell differentiation, 3/19,146/18614,4.18E-04,0.008270269,0.004570061,HNRNPU/SFRP1/AXIN2,3
GO:0006359,regulation of transcription by RNA polymerase III, 2/19,30/18614,4.22E-04,0.008270269,0.004570061,MYBBP1A/DDX21,2
GO:0035066,positive regulation of histone acetylation, 2/19,30/18614,4.22E-04,0.008270269,0.004570061,MYBBP1A/DDX21,2
GO:0045667,regulation of osteoblast differentiation, 3/19,147/18614,4.26E-04,0.008270269,0.004570061,SFRP1/AXIN2/IFITM1,3
GO:0033688,regulation of osteoblast proliferation, 2/19,31/18614,4.51E-04,0.008617149,0.004761744,SFRP1/AXIN2,2
GO:0030336,negative regulation of cell migration, 4/19,375/18614,4.94E-04,0.009303349,0.00514093,GTPBP4/SFRP1/IGFBP3/IFITM1,4
GO:0042326,negative regulation of phosphorylation, 4/19,383/18614,5.35E-04,0.009923604,0.005483676,HNRNPU/SFRP1/IGFBP3/ADAR,4
GO:2000146,negative regulation of cell motility, 4/19,390/18614,5.73E-04,0.010363836,0.005726944,GTPBP4/SFRP1/IGFBP3/IFITM1,4
GO:0050792,regulation of viral process, 3/19,165/18614,5.97E-04,0.010363836,0.005726944,DHX9/IFITM1/ADAR,3
GO:0051168,nuclear export, 3/19,166/18614,6.08E-04,0.010363836,0.005726944,SIRT7/DHX9/ALYREF,3
GO:0033687,osteoblast proliferation, 2/19,36/18614,6.09E-04,0.010363836,0.005726944,SFRP1/AXIN2,2
GO:1900368,regulation of post-transcriptional gene silencing by RNA, 2/19,36/18614,6.09E-04,0.010363836,0.005726944,DHX9/ADAR,2
GO:2000758,positive regulation of peptidyl-lysine acetylation, 2/19,36/18614,6.09E-04,0.010363836,0.005726944,MYBBP1A/DDX21,2
GO:0034250,positive regulation of amide metabolic process, 3/19,169/18614,6.40E-04,0.010657408,0.005889168,HNRNPU/SYNCRIP/DHX9,3
GO:0060147,regulation of post-transcriptional gene silencing, 2/19,37/18614,6.44E-04,0.010657408,0.005889168,DHX9/ADAR,2
GO:0001837,epithelial to mesenchymal transition, 3/19,172/18614,6.74E-04,0.010950628,0.006051199,SFRP1/HIF1A/AXIN2,3
GO:0060966,regulation of gene silencing by RNA, 2/19,38/18614,6.79E-04,0.010950628,0.006051199,DHX9/ADAR,2
GO:0030279,negative regulation of ossification, 2/19,39/18614,7.15E-04,0.011387643,0.006292688,SFRP1/HIF1A,2
GO:0060759,regulation of response to cytokine stimulus, 3/19,177/18614,7.32E-04,0.011512143,0.006361486,DHX9/HIF1A/ADAR,3
GO:0030099,myeloid cell differentiation, 4/19,421/18614,7.64E-04,0.011854677,0.006550766,SFRP1/RUNX1/HIF1A/ADAR,4
GO:0048771,tissue remodeling, 3/19,181/18614,7.81E-04,0.011980036,0.006620038,SFRP1/RUNX1/HIF1A,3
GO:0040013,negative regulation of locomotion, 4/19,427/18614,8.05E-04,0.01206985,0.006669669,GTPBP4/SFRP1/IGFBP3/IFITM1,4
GO:0006109,regulation of carbohydrate metabolic process, 3/19,183/18614,8.07E-04,0.01206985,0.006669669,SIRT7/HIF1A/IGFBP3,3
GO:0071542,dopaminergic neuron differentiation, 2/19,42/18614,8.29E-04,0.012264267,0.006777101,SFRP1/HIF1A,2
GO:0045936,negative regulation of phosphate metabolic process, 4/19,439/18614,8.93E-04,0.013003859,0.007185792,HNRNPU/SFRP1/IGFBP3/ADAR,4
GO:0010563,negative regulation of phosphorus metabolic process, 4/19,440/18614,9.00E-04,0.013003859,0.007185792,HNRNPU/SFRP1/IGFBP3/ADAR,4
GO:0032781,positive regulation of ATP-dependent activity, 2/19,45/18614,9.52E-04,0.013478001,0.007447798,HNRNPU/DHX9,2
GO:0034655,nucleobase-containing compound catabolic process, 4/19,447/18614,9.55E-04,0.013478001,0.007447798,HNRNPU/SYNCRIP/DHX9/AXIN2,4
GO:1901985,positive regulation of protein acetylation, 2/19,47/18614,0.001038248,0.014488811,0.008006361,MYBBP1A/DDX21,2
GO:0043330,response to exogenous dsRNA, 2/19,49/18614,0.001128118,0.015568031,0.008602726,DHX9/DDX21,2
GO:0048546,digestive tract morphogenesis, 2/19,50/18614,0.001174409,0.015981307,0.008831098,SFRP1/HIF1A,2
GO:0071383,cellular response to steroid hormone stimulus, 3/19,209/18614,0.001184011,0.015981307,0.008831098,HNRNPU/SFRP1/AXIN2,3
GO:0016570,histone modification, 4/19,475/18614,0.001196668,0.015981307,0.008831098,MYBBP1A/SIRT7/DDX21/FBL,4
GO:0006282,regulation of DNA repair, 3/19,214/18614,0.001267375,0.016569255,0.009155991,SIRT7/DHX9/AXIN2,3
GO:0045637,regulation of myeloid cell differentiation, 3/19,214/18614,0.001267375,0.016569255,0.009155991,SFRP1/RUNX1/HIF1A,3
GO:0044270,cellular nitrogen compound catabolic process, 4/19,486/18614,0.001302457,0.016715767,0.009236952,HNRNPU/SYNCRIP/DHX9/AXIN2,4
GO:0035065,regulation of histone acetylation, 2/19,53/18614,0.001318682,0.016715767,0.009236952,MYBBP1A/DDX21,2
GO:0046700,heterocycle catabolic process, 4/19,488/18614,0.001322377,0.016715767,0.009236952,HNRNPU/SYNCRIP/DHX9/AXIN2,4
GO:0001819,positive regulation of cytokine production, 4/19,489/18614,0.001332416,0.016715767,0.009236952,DHX9/RUNX1/HIF1A/DDX21,4
GO:0006383,transcription by RNA polymerase III, 2/19,54/18614,0.001368569,0.01682933,0.009299706,MYBBP1A/DDX21,2
GO:0071385,cellular response to glucocorticoid stimulus, 2/19,54/18614,0.001368569,0.01682933,0.009299706,HNRNPU/AXIN2,2
GO:0000381,"regulation of alternative mRNA splicing, via spliceosome", 2/19,56/18614,0.001471024,0.017737974,0.009801813,HNRNPU/RBMX,2
GO:0043331,response to dsRNA, 2/19,56/18614,0.001471024,0.017737974,0.009801813,DHX9/DDX21,2
GO:1903053,regulation of extracellular matrix organization, 2/19,59/18614,0.001631387,0.019482522,0.010765831,RUNX1/AXIN2,2
GO:0045620,negative regulation of lymphocyte differentiation, 2/19,60/18614,0.001686616,0.019950256,0.011024296,SFRP1/RUNX1,2
GO:0033673,negative regulation of kinase activity, 3/19,239/18614,0.001739795,0.020228694,0.011178158,HNRNPU/SFRP1/ADAR,3
GO:0045668,negative regulation of osteoblast differentiation, 2/19,61/18614,0.00174273,0.020228694,0.011178158,SFRP1/AXIN2,2
GO:2000756,regulation of peptidyl-lysine acetylation, 2/19,62/18614,0.001799726,0.020696855,0.011436858,MYBBP1A/DDX21,2
GO:0045444,fat cell differentiation, 3/19,246/18614,0.001889322,0.021251089,0.011743122,HNRNPU/SFRP1/AXIN2,3
GO:0048863,stem cell differentiation, 3/19,247/18614,0.001911318,0.021251089,0.011743122,HNRNPU/SFRP1/HIF1A,3
GO:0048524,positive regulation of viral process, 2/19,64/18614,0.001916362,0.021251089,0.011743122,DHX9/ADAR,2
GO:0071384,cellular response to corticosteroid stimulus, 2/19,64/18614,0.001916362,0.021251089,0.011743122,HNRNPU/AXIN2,2
GO:0001756,somitogenesis, 2/19,66/18614,0.00203651,0.022187239,0.012260429,SFRP1/AXIN2,2
GO:0060760,positive regulation of response to cytokine stimulus, 2/19,66/18614,0.00203651,0.022187239,0.012260429,DHX9/HIF1A,2
GO:0048762,mesenchymal cell differentiation, 3/19,255/18614,0.002093096,0.022410564,0.012383836,SFRP1/HIF1A/AXIN2,3
GO:1903320,regulation of protein modification by small protein conjugation or removal, 3/19,255/18614,0.002093096,0.022410564,0.012383836,GTPBP4/SIRT7/HIF1A,3
GO:0042273,ribosomal large subunit biogenesis, 2/19,69/18614,0.002223287,0.023601046,0.013041683,GTPBP4/RPL38,2
GO:0032922,circadian regulation of gene expression, 2/19,71/18614,0.002352156,0.024757439,0.013680694,HNRNPU/MYBBP1A,2
GO:0043462,regulation of ATP-dependent activity, 2/19,73/18614,0.002484491,0.025930567,0.014328951,HNRNPU/DHX9,2
GO:0017148,negative regulation of translation, 3/19,276/18614,0.002620639,0.02712361,0.014988214,HNRNPU/SYNCRIP/DHX9,3
GO:0006260,DNA replication, 3/19,278/18614,0.002674782,0.027284757,0.015077262,GTPBP4/DHX9/ALYREF,3
GO:0060337,type I interferon-mediated signaling pathway, 2/19,76/18614,0.002689462,0.027284757,0.015077262,IFITM1/ADAR,2
GO:0051348,negative regulation of transferase activity, 3/19,279/18614,0.002702114,0.027284757,0.015077262,HNRNPU/SFRP1/ADAR,3
GO:0071357,cellular response to type I interferon, 2/19,77/18614,0.002759504,0.027418431,0.015151129,IFITM1/ADAR,2
GO:1901983,regulation of protein acetylation, 2/19,77/18614,0.002759504,0.027418431,0.015151129,MYBBP1A/DDX21,2
GO:0008088,axo-dendritic transport, 2/19,78/18614,0.002830403,0.027899683,0.015417064,HNRNPU/HIF1A,2
GO:0034340,response to type I interferon, 2/19,83/18614,0.003197687,0.031271868,0.017280497,IFITM1/ADAR,2
GO:2000113,negative regulation of cellular macromolecule biosynthetic process, 3/19,301/18614,0.003347914,0.031672801,0.017502048,HNRNPU/SYNCRIP/DHX9,3
GO:0031397,negative regulation of protein ubiquitination, 2/19,85/18614,0.003350539,0.031672801,0.017502048,GTPBP4/SIRT7,2
GO:0098586,cellular response to virus, 2/19,85/18614,0.003350539,0.031672801,0.017502048,HIF1A/ADAR,2
GO:0048511,rhythmic process, 3/19,303/18614,0.00341092,0.031672801,0.017502048,HNRNPU/MYBBP1A/DHX9,3
GO:0034103,regulation of tissue remodeling, 2/19,86/18614,0.003428232,0.031672801,0.017502048,SFRP1/RUNX1,2
GO:0045069,regulation of viral genome replication, 2/19,86/18614,0.003428232,0.031672801,0.017502048,IFITM1/ADAR,2
GO:0061053,somite development, 2/19,86/18614,0.003428232,0.031672801,0.017502048,SFRP1/AXIN2,2
GO:0034249,negative regulation of amide metabolic process, 3/19,304/18614,0.003442696,0.031672801,0.017502048,HNRNPU/SYNCRIP/DHX9,3
GO:0048145,regulation of fibroblast proliferation, 2/19,87/18614,0.003506766,0.032025024,0.017696683,DHX9/SFRP1,2
GO:0031058,positive regulation of histone modification, 2/19,88/18614,0.00358614,0.03251085,0.017965145,MYBBP1A/DDX21,2
GO:2001020,regulation of response to DNA damage stimulus, 3/19,311/18614,0.003670256,0.033032304,0.018253294,SIRT7/DHX9/AXIN2,3
GO:0006405,RNA export from nucleus, 2/19,90/18614,0.003747404,0.033483997,0.018502895,DHX9/ALYREF,2
GO:0009798,axis specification, 2/19,92/18614,0.003912009,0.03470511,0.019177669,SFRP1/AXIN2,2
GO:0060485,mesenchyme development, 3/19,320/18614,0.003976162,0.035024062,0.019353919,SFRP1/HIF1A/AXIN2,3
GO:0009953,dorsal/ventral pattern formation, 2/19,95/18614,0.004165155,0.036175681,0.019990291,SFRP1/AXIN2,2
GO:0014033,neural crest cell differentiation, 2/19,95/18614,0.004165155,0.036175681,0.019990291,SFRP1/HIF1A,2
GO:0006913,nucleocytoplasmic transport, 3/19,328/18614,0.004260847,0.036496357,0.020167493,SIRT7/DHX9/ALYREF,3
GO:0051169,nuclear transport, 3/19,328/18614,0.004260847,0.036496357,0.020167493,SIRT7/DHX9/ALYREF,3
GO:0014020,primary neural tube formation, 2/19,97/18614,0.004338059,0.036652169,0.020253593,SFRP1/HIF1A,2
GO:1903321,negative regulation of protein modification by small protein conjugation or removal, 2/19,97/18614,0.004338059,0.036652169,0.020253593,GTPBP4/SIRT7,2
GO:0062012,regulation of small molecule metabolic process, 3/19,331/18614,0.004370738,0.03667876,0.020268286,SIRT7/HIF1A/IGFBP3,3
GO:0035282,segmentation, 2/19,100/18614,0.004603592,0.038117744,0.021063454,SFRP1/AXIN2,2
GO:0140888,interferon-mediated signaling pathway, 2/19,100/18614,0.004603592,0.038117744,0.021063454,IFITM1/ADAR,2
GO:0048545,response to steroid hormone, 3/19,339/18614,0.004672226,0.038429829,0.021235909,HNRNPU/SFRP1/AXIN2,3
GO:0001933,negative regulation of protein phosphorylation, 3/19,341/18614,0.00474953,0.038808662,0.021445247,SFRP1/IGFBP3/ADAR,3
GO:0010906,regulation of glucose metabolic process, 2/19,103/18614,0.004876501,0.039074934,0.021592387,SIRT7/IGFBP3,2
GO:0045639,positive regulation of myeloid cell differentiation, 2/19,103/18614,0.004876501,0.039074934,0.021592387,RUNX1/HIF1A,2
GO:0048144,fibroblast proliferation, 2/19,103/18614,0.004876501,0.039074934,0.021592387,DHX9/SFRP1,2
GO:0001841,neural tube formation, 2/19,105/18614,0.005062517,0.039826945,0.02200794,SFRP1/HIF1A,2
GO:0032784,regulation of DNA-templated transcription elongation, 2/19,105/18614,0.005062517,0.039826945,0.02200794,HNRNPU/ALYREF,2
GO:0045765,regulation of angiogenesis, 3/19,349/18614,0.005066552,0.039826945,0.02200794,SFRP1/RUNX1/HIF1A,3
GO:0046822,regulation of nucleocytoplasmic transport, 2/19,107/18614,0.005251779,0.040746926,0.022516311,SIRT7/DHX9,2
GO:1901655,cellular response to ketone, 2/19,107/18614,0.005251779,0.040746926,0.022516311,SFRP1/AXIN2,2
GO:1901342,regulation of vasculature development, 3/19,355/18614,0.005312577,0.040746926,0.022516311,SFRP1/RUNX1/HIF1A,3
GO:0032963,collagen metabolic process, 2/19,108/18614,0.005347624,0.040746926,0.022516311,RUNX1/HIF1A,2
GO:0048024,"regulation of mRNA splicing, via spliceosome", 2/19,108/18614,0.005347624,0.040746926,0.022516311,HNRNPU/RBMX,2
GO:1902106,negative regulation of leukocyte differentiation, 2/19,109/18614,0.005444275,0.041230426,0.022783488,SFRP1/RUNX1,2
GO:0010717,regulation of epithelial to mesenchymal transition, 2/19,110/18614,0.005541732,0.041714128,0.023050777,SFRP1/AXIN2,2
GO:0002062,chondrocyte differentiation, 2/19,113/18614,0.005838918,0.043686365,0.024140614,HIF1A/AXIN2,2
GO:1903707,negative regulation of hemopoiesis, 2/19,115/18614,0.00604104,0.044927978,0.024826715,SFRP1/RUNX1,2
GO:0018205,peptidyl-lysine modification, 3/19,374/18614,0.006139094,0.045385447,0.025079508,MYBBP1A/SIRT7/DDX21,3
GO:0030278,regulation of ossification, 2/19,119/18614,0.006454824,0.047437224,0.026213298,SFRP1/HIF1A,2
GO:0030282,bone mineralization, 2/19,121/18614,0.00666646,0.048704371,0.026913509,HIF1A/AXIN2,2
GO:0002761,regulation of myeloid leukocyte differentiation, 2/19,123/18614,0.006881243,0.049979551,0.02761816,SFRP1/RUNX1,2
GO:0001838,embryonic epithelial tube formation, 2/19,126/18614,0.00720929,0.052057778,0.028766566,SFRP1/HIF1A,2
GO:0006338,chromatin remodeling, 3/19,402/18614,0.007491611,0.053543312,0.029587456,MYBBP1A/SIRT7/DDX21,3
GO:0006354,DNA-templated transcription elongation, 2/19,129/18614,0.007544348,0.053543312,0.029587456,HNRNPU/ALYREF,2
GO:0019079,viral genome replication, 2/19,129/18614,0.007544348,0.053543312,0.029587456,IFITM1/ADAR,2
GO:0030218,erythrocyte differentiation, 2/19,130/18614,0.007657584,0.053732879,0.029692209,HIF1A/ADAR,2
GO:0051028,mRNA transport, 2/19,130/18614,0.007657584,0.053732879,0.029692209,DHX9/ALYREF,2
GO:0002244,hematopoietic progenitor cell differentiation, 2/19,132/18614,0.007886375,0.055027401,0.030407548,SFRP1/ADAR,2
GO:0048565,digestive tract development, 2/19,134/18614,0.008118244,0.056328825,0.0311267,SFRP1/HIF1A,2
GO:1903706,regulation of hemopoiesis, 3/19,415/18614,0.008175333,0.056409796,0.031171444,SFRP1/RUNX1/HIF1A,3
GO:0006275,regulation of DNA replication, 2/19,136/18614,0.008353181,0.057318514,0.031673592,GTPBP4/DHX9,2
GO:0003002,regionalization, 3/19,422/18614,0.00855839,0.058169075,0.032143603,SFRP1/HIF1A/AXIN2,3
GO:0072175,epithelial tube formation, 2/19,138/18614,0.008591173,0.058169075,0.032143603,SFRP1/HIF1A,2
GO:0034101,erythrocyte homeostasis, 2/19,139/18614,0.008711311,0.058169075,0.032143603,HIF1A/ADAR,2
GO:0034341,response to type II interferon, 2/19,139/18614,0.008711311,0.058169075,0.032143603,SYNCRIP/IFITM1,2
GO:0090090,negative regulation of canonical Wnt signaling pathway, 2/19,139/18614,0.008711311,0.058169075,0.032143603,SFRP1/AXIN2,2
GO:0016032,viral process, 3/19,426/18614,0.008781998,0.058327497,0.032231145,DHX9/IFITM1/ADAR,3
GO:0031056,regulation of histone modification, 2/19,141/18614,0.008953862,0.059152644,0.032687112,MYBBP1A/DDX21,2
GO:0051384,response to glucocorticoid, 2/19,142/18614,0.009076273,0.059644081,0.032958675,HNRNPU/AXIN2,2
GO:1903900,regulation of viral life cycle, 2/19,143/18614,0.009199439,0.060135279,0.033230106,IFITM1/ADAR,2
GO:0055123,digestive system development, 2/19,146/18614,0.009573449,0.062252478,0.034400047,SFRP1/HIF1A,2
GO:0051053,negative regulation of DNA metabolic process, 2/19,148/18614,0.009826535,0.062787117,0.034695483,HNRNPU/GTPBP4,2
GO:0071456,cellular response to hypoxia, 2/19,149/18614,0.009954197,0.062787117,0.034695483,SFRP1/HIF1A,2
GO:0046886,positive regulation of hormone biosynthetic process, 1/19,10/18614,0.010163058,0.062787117,0.034695483,HIF1A,1
GO:0048865,stem cell fate commitment, 1/19,10/18614,0.010163058,0.062787117,0.034695483,SFRP1,1
GO:0060346,bone trabecula formation, 1/19,10/18614,0.010163058,0.062787117,0.034695483,SFRP1,1
GO:0060525,prostate glandular acinus development, 1/19,10/18614,0.010163058,0.062787117,0.034695483,SFRP1,1
GO:0070099,regulation of chemokine-mediated signaling pathway, 1/19,10/18614,0.010163058,0.062787117,0.034695483,HIF1A,1
GO:2000234,positive regulation of rRNA processing, 1/19,10/18614,0.010163058,0.062787117,0.034695483,SIRT7,1
GO:2000271,positive regulation of fibroblast apoptotic process, 1/19,10/18614,0.010163058,0.062787117,0.034695483,SFRP1,1
GO:2001054,negative regulation of mesenchymal cell apoptotic process, 1/19,10/18614,0.010163058,0.062787117,0.034695483,HIF1A,1
GO:0010821,regulation of mitochondrion organization, 2/19,151/18614,0.010211753,0.062787117,0.034695483,SIRT7/HIF1A,2
GO:0010675,regulation of cellular carbohydrate metabolic process, 2/19,152/18614,0.010341644,0.062962362,0.034792322,SIRT7/IGFBP3,2
GO:0016331,morphogenesis of embryonic epithelium, 2/19,152/18614,0.010341644,0.062962362,0.034792322,SFRP1/HIF1A,2
GO:0016573,histone acetylation, 2/19,153/18614,0.010472275,0.063446659,0.035059938,MYBBP1A/DDX21,2
GO:0035148,tube formation, 2/19,154/18614,0.010603643,0.063930704,0.035327417,SFRP1/HIF1A,2
GO:0036294,cellular response to decreased oxygen levels, 2/19,157/18614,0.011002165,0.0647306,0.03576943,SFRP1/HIF1A,2
GO:0003139,secondary heart field specification, 1/19,11/18614,0.011173965,0.0647306,0.03576943,AXIN2,1
GO:0003183,mitral valve morphogenesis, 1/19,11/18614,0.011173965,0.0647306,0.03576943,AXIN2,1
GO:0051987,positive regulation of attachment of spindle microtubules to kinetochore, 1/19,11/18614,0.011173965,0.0647306,0.03576943,HNRNPU,1
GO:0061418,regulation of transcription from RNA polymerase II promoter in response to hypoxia, 1/19,11/18614,0.011173965,0.0647306,0.03576943,HIF1A,1
GO:0070601,centromeric sister chromatid cohesion, 1/19,11/18614,0.011173965,0.0647306,0.03576943,AXIN2,1
GO:0090179,planar cell polarity pathway involved in neural tube closure, 1/19,11/18614,0.011173965,0.0647306,0.03576943,SFRP1,1
GO:0007389,pattern specification process, 3/19,467/18614,0.011274929,0.0647306,0.03576943,SFRP1/HIF1A/AXIN2,3
GO:0050657,nucleic acid transport, 2/19,160/18614,0.011407279,0.0647306,0.03576943,DHX9/ALYREF,2
GO:0050658,RNA transport, 2/19,160/18614,0.011407279,0.0647306,0.03576943,DHX9/ALYREF,2
GO:0018393,internal peptidyl-lysine acetylation, 2/19,161/18614,0.011543775,0.0647306,0.03576943,MYBBP1A/DDX21,2
GO:0006475,internal protein amino acid acetylation, 2/19,163/18614,0.011818945,0.0647306,0.03576943,MYBBP1A/DDX21,2
GO:0021915,neural tube development, 2/19,163/18614,0.011818945,0.0647306,0.03576943,SFRP1/HIF1A,2
GO:0050796,regulation of insulin secretion, 2/19,163/18614,0.011818945,0.0647306,0.03576943,SFRP1/HIF1A,2
GO:0051236,establishment of RNA localization, 2/19,163/18614,0.011818945,0.0647306,0.03576943,DHX9/ALYREF,2
GO:0001959,regulation of cytokine-mediated signaling pathway, 2/19,165/18614,0.012097009,0.0647306,0.03576943,HIF1A/ADAR,2
GO:0002069,columnar/cuboidal epithelial cell maturation, 1/19,12/18614,0.012183893,0.0647306,0.03576943,HIF1A,1
GO:0002732,positive regulation of dendritic cell cytokine production, 1/19,12/18614,0.012183893,0.0647306,0.03576943,DDX21,1
GO:0003174,mitral valve development, 1/19,12/18614,0.012183893,0.0647306,0.03576943,AXIN2,1
GO:0031126,sno(s)RNA 3'-end processing, 1/19,12/18614,0.012183893,0.0647306,0.03576943,FBL,1
GO:0046831,regulation of RNA export from nucleus, 1/19,12/18614,0.012183893,0.0647306,0.03576943,DHX9,1
GO:0060442,branching involved in prostate gland morphogenesis, 1/19,12/18614,0.012183893,0.0647306,0.03576943,SFRP1,1
GO:0070932,histone H3 deacetylation, 1/19,12/18614,0.012183893,0.0647306,0.03576943,SIRT7,1
GO:0090178,regulation of establishment of planar polarity involved in neural tube closure, 1/19,12/18614,0.012183893,0.0647306,0.03576943,SFRP1,1
GO:1904338,regulation of dopaminergic neuron differentiation, 1/19,12/18614,0.012183893,0.0647306,0.03576943,SFRP1,1
GO:0031960,response to corticosteroid, 2/19,166/18614,0.012237123,0.0647306,0.03576943,HNRNPU/AXIN2,2
GO:0051250,negative regulation of lymphocyte activation, 2/19,168/18614,0.012519508,0.0647306,0.03576943,SFRP1/RUNX1,2
GO:0002683,negative regulation of immune system process, 3/19,487/18614,0.012626136,0.0647306,0.03576943,SFRP1/RUNX1/ADAR,3
GO:0050673,epithelial cell proliferation, 3/19,488/18614,0.012696056,0.0647306,0.03576943,SFRP1/HIF1A/IGFBP3,3
GO:0009267,cellular response to starvation, 2/19,170/18614,0.012804758,0.0647306,0.03576943,MYBBP1A/SFRP1,2
GO:0002262,myeloid cell homeostasis, 2/19,171/18614,0.012948454,0.0647306,0.03576943,HIF1A/ADAR,2
GO:0019221,cytokine-mediated signaling pathway, 3/19,492/18614,0.012977996,0.0647306,0.03576943,HIF1A/IFITM1/ADAR,3
GO:0010970,transport along microtubule, 2/19,172/18614,0.013092862,0.0647306,0.03576943,HNRNPU/HIF1A,2
GO:0018394,peptidyl-lysine acetylation, 2/19,172/18614,0.013092862,0.0647306,0.03576943,MYBBP1A/DDX21,2
GO:0071453,cellular response to oxygen levels, 2/19,172/18614,0.013092862,0.0647306,0.03576943,SFRP1/HIF1A,2
GO:0002566,somatic diversification of immune receptors via somatic mutation, 1/19,13/18614,0.013192844,0.0647306,0.03576943,ADAR,1
GO:0032621,interleukin-18 production, 1/19,13/18614,0.013192844,0.0647306,0.03576943,DHX9,1
GO:0032661,regulation of interleukin-18 production, 1/19,13/18614,0.013192844,0.0647306,0.03576943,DHX9,1
GO:0043568,positive regulation of insulin-like growth factor receptor signaling pathway, 1/19,13/18614,0.013192844,0.0647306,0.03576943,IGFBP3,1
GO:0061430,bone trabecula morphogenesis, 1/19,13/18614,0.013192844,0.0647306,0.03576943,SFRP1,1
GO:0070243,regulation of thymocyte apoptotic process, 1/19,13/18614,0.013192844,0.0647306,0.03576943,HIF1A,1
GO:0071481,cellular response to X-ray, 1/19,13/18614,0.013192844,0.0647306,0.03576943,SFRP1,1
GO:0090177,establishment of planar polarity involved in neural tube closure, 1/19,13/18614,0.013192844,0.0647306,0.03576943,SFRP1,1
GO:0090235,regulation of metaphase plate congression, 1/19,13/18614,0.013192844,0.0647306,0.03576943,HNRNPU,1
GO:0098935,dendritic transport, 1/19,13/18614,0.013192844,0.0647306,0.03576943,HNRNPU,1
GO:1903599,positive regulation of autophagy of mitochondrion, 1/19,13/18614,0.013192844,0.0647306,0.03576943,HIF1A,1
GO:2001053,regulation of mesenchymal cell apoptotic process, 1/19,13/18614,0.013192844,0.0647306,0.03576943,HIF1A,1
GO:0031214,biomineral tissue development, 2/19,173/18614,0.013237981,0.0647306,0.03576943,HIF1A/AXIN2,2
GO:0030178,negative regulation of Wnt signaling pathway, 2/19,174/18614,0.013383809,0.065187021,0.036021644,SFRP1/AXIN2,2
GO:0009451,RNA modification, 2/19,177/18614,0.013825533,0.067075436,0.037065162,ADAR/FBL,2
GO:0042541,hemoglobin biosynthetic process, 1/19,14/18614,0.014200819,0.067836218,0.037485562,HIF1A,1
GO:0043144,sno(s)RNA processing, 1/19,14/18614,0.014200819,0.067836218,0.037485562,FBL,1
GO:1902043,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors, 1/19,14/18614,0.014200819,0.067836218,0.037485562,SFRP1,1
GO:1905203,regulation of connective tissue replacement, 1/19,14/18614,0.014200819,0.067836218,0.037485562,RUNX1,1
GO:0043484,regulation of RNA splicing, 2/19,182/18614,0.014575789,0.068188122,0.03768002,HNRNPU/RBMX,2
GO:0045766,positive regulation of angiogenesis, 2/19,185/18614,0.015034309,0.068188122,0.03768002,RUNX1/HIF1A,2
GO:1904018,positive regulation of vasculature development, 2/19,185/18614,0.015034309,0.068188122,0.03768002,RUNX1/HIF1A,2
GO:0000463,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)", 1/19,15/18614,0.015207818,0.068188122,0.03768002,GTPBP4,1
GO:0003413,chondrocyte differentiation involved in endochondral bone morphogenesis, 1/19,15/18614,0.015207818,0.068188122,0.03768002,AXIN2,1
GO:0014029,neural crest formation, 1/19,15/18614,0.015207818,0.068188122,0.03768002,SFRP1,1
GO:0032239,regulation of nucleobase-containing compound transport, 1/19,15/18614,0.015207818,0.068188122,0.03768002,DHX9,1
GO:0032352,positive regulation of hormone metabolic process, 1/19,15/18614,0.015207818,0.068188122,0.03768002,HIF1A,1
GO:0043374,"CD8-positive, alpha-beta T cell differentiation", 1/19,15/18614,0.015207818,0.068188122,0.03768002,RUNX1,1
GO:0048934,peripheral nervous system neuron differentiation, 1/19,15/18614,0.015207818,0.068188122,0.03768002,RUNX1,1
GO:0048935,peripheral nervous system neuron development, 1/19,15/18614,0.015207818,0.068188122,0.03768002,RUNX1,1
GO:0060026,convergent extension, 1/19,15/18614,0.015207818,0.068188122,0.03768002,SFRP1,1
GO:0060766,negative regulation of androgen receptor signaling pathway, 1/19,15/18614,0.015207818,0.068188122,0.03768002,SFRP1,1
GO:0071380,cellular response to prostaglandin E stimulus, 1/19,15/18614,0.015207818,0.068188122,0.03768002,SFRP1,1
GO:0097152,mesenchymal cell apoptotic process, 1/19,15/18614,0.015207818,0.068188122,0.03768002,HIF1A,1
GO:1901836,regulation of transcription of nucleolar large rRNA by RNA polymerase I, 1/19,15/18614,0.015207818,0.068188122,0.03768002,SIRT7,1
GO:2000052,positive regulation of non-canonical Wnt signaling pathway, 1/19,15/18614,0.015207818,0.068188122,0.03768002,SFRP1,1
GO:0006006,glucose metabolic process, 2/19,187/18614,0.015343452,0.068548802,0.037879328,SIRT7/IGFBP3,2
GO:0090276,regulation of peptide hormone secretion, 2/19,192/18614,0.016128345,0.06968025,0.038504554,SFRP1/HIF1A,2
GO:0030852,regulation of granulocyte differentiation, 1/19,16/18614,0.016213842,0.06968025,0.038504554,RUNX1,1
GO:0031054,pre-miRNA processing, 1/19,16/18614,0.016213842,0.06968025,0.038504554,ADAR,1
GO:0042249,establishment of planar polarity of embryonic epithelium, 1/19,16/18614,0.016213842,0.06968025,0.038504554,SFRP1,1
GO:0043508,negative regulation of JUN kinase activity, 1/19,16/18614,0.016213842,0.06968025,0.038504554,SFRP1,1
GO:0060576,intestinal epithelial cell development, 1/19,16/18614,0.016213842,0.06968025,0.038504554,HIF1A,1
GO:0061469,regulation of type B pancreatic cell proliferation, 1/19,16/18614,0.016213842,0.06968025,0.038504554,SFRP1,1
GO:0090336,positive regulation of brown fat cell differentiation, 1/19,16/18614,0.016213842,0.06968025,0.038504554,HNRNPU,1
GO:2000095,"regulation of Wnt signaling pathway, planar cell polarity pathway", 1/19,16/18614,0.016213842,0.06968025,0.038504554,SFRP1,1
GO:2000232,regulation of rRNA processing, 1/19,16/18614,0.016213842,0.06968025,0.038504554,SIRT7,1
GO:2000637,positive regulation of miRNA-mediated gene silencing, 1/19,16/18614,0.016213842,0.06968025,0.038504554,DHX9,1
GO:0002791,regulation of peptide secretion, 2/19,195/18614,0.016607478,0.070826774,0.039138111,SFRP1/HIF1A,2
GO:0030073,insulin secretion, 2/19,197/18614,0.016930292,0.070826774,0.039138111,SFRP1/HIF1A,2
GO:0090087,regulation of peptide transport, 2/19,197/18614,0.016930292,0.070826774,0.039138111,SFRP1/HIF1A,2
GO:0002730,regulation of dendritic cell cytokine production, 1/19,17/18614,0.017218893,0.070826774,0.039138111,DDX21,1
GO:0006089,lactate metabolic process, 1/19,17/18614,0.017218893,0.070826774,0.039138111,HIF1A,1
GO:0016074,sno(s)RNA metabolic process, 1/19,17/18614,0.017218893,0.070826774,0.039138111,FBL,1
GO:0030949,positive regulation of vascular endothelial growth factor receptor signaling pathway, 1/19,17/18614,0.017218893,0.070826774,0.039138111,HIF1A,1
GO:0060148,positive regulation of post-transcriptional gene silencing, 1/19,17/18614,0.017218893,0.070826774,0.039138111,DHX9,1
GO:0071360,cellular response to exogenous dsRNA, 1/19,17/18614,0.017218893,0.070826774,0.039138111,DHX9,1
GO:1900370,positive regulation of post-transcriptional gene silencing by RNA, 1/19,17/18614,0.017218893,0.070826774,0.039138111,DHX9,1
GO:1904948,midbrain dopaminergic neuron differentiation, 1/19,17/18614,0.017218893,0.070826774,0.039138111,SFRP1,1
GO:0002695,negative regulation of leukocyte activation, 2/19,202/18614,0.017749119,0.070826774,0.039138111,SFRP1/RUNX1,2
GO:0051216,cartilage development, 2/19,203/18614,0.017914894,0.070826774,0.039138111,HIF1A/AXIN2,2
GO:0002371,dendritic cell cytokine production, 1/19,18/18614,0.018222971,0.070826774,0.039138111,DDX21,1
GO:0003128,heart field specification, 1/19,18/18614,0.018222971,0.070826774,0.039138111,AXIN2,1
GO:0007063,regulation of sister chromatid cohesion, 1/19,18/18614,0.018222971,0.070826774,0.039138111,AXIN2,1
GO:0010755,regulation of plasminogen activation, 1/19,18/18614,0.018222971,0.070826774,0.039138111,RUNX1,1
GO:0019081,viral translation, 1/19,18/18614,0.018222971,0.070826774,0.039138111,DHX9,1
GO:0019896,axonal transport of mitochondrion, 1/19,18/18614,0.018222971,0.070826774,0.039138111,HIF1A,1
GO:0020027,hemoglobin metabolic process, 1/19,18/18614,0.018222971,0.070826774,0.039138111,HIF1A,1
GO:0036003,positive regulation of transcription from RNA polymerase II promoter in response to stress, 1/19,18/18614,0.018222971,0.070826774,0.039138111,HIF1A,1
GO:0046851,negative regulation of bone remodeling, 1/19,18/18614,0.018222971,0.070826774,0.039138111,SFRP1,1
GO:0051988,regulation of attachment of spindle microtubules to kinetochore, 1/19,18/18614,0.018222971,0.070826774,0.039138111,HNRNPU,1
GO:0060149,negative regulation of post-transcriptional gene silencing, 1/19,18/18614,0.018222971,0.070826774,0.039138111,ADAR,1
GO:0060644,mammary gland epithelial cell differentiation, 1/19,18/18614,0.018222971,0.070826774,0.039138111,HIF1A,1
GO:0060967,negative regulation of gene silencing by RNA, 1/19,18/18614,0.018222971,0.070826774,0.039138111,ADAR,1
GO:0061298,retina vasculature development in camera-type eye, 1/19,18/18614,0.018222971,0.070826774,0.039138111,HIF1A,1
GO:0071391,cellular response to estrogen stimulus, 1/19,18/18614,0.018222971,0.070826774,0.039138111,SFRP1,1
GO:0090594,inflammatory response to wounding, 1/19,18/18614,0.018222971,0.070826774,0.039138111,HIF1A,1
GO:1900369,negative regulation of post-transcriptional gene silencing by RNA, 1/19,18/18614,0.018222971,0.070826774,0.039138111,ADAR,1
GO:0022408,negative regulation of cell-cell adhesion, 2/19,205/18614,0.018248444,0.070826774,0.039138111,GTPBP4/RUNX1,2
GO:0051701,biological process involved in interaction with host, 2/19,206/18614,0.018416216,0.071067823,0.039271311,IFITM1/ALYREF,2
GO:0007623,circadian rhythm, 2/19,207/18614,0.018584651,0.071067823,0.039271311,HNRNPU/MYBBP1A,2
GO:0042594,response to starvation, 2/19,207/18614,0.018584651,0.071067823,0.039271311,MYBBP1A/SFRP1,2
GO:0006473,protein acetylation, 2/19,208/18614,0.018753747,0.071067823,0.039271311,MYBBP1A/DDX21,2
GO:1901654,response to ketone, 2/19,208/18614,0.018753747,0.071067823,0.039271311,SFRP1/AXIN2,2
GO:0009952,anterior/posterior pattern specification, 2/19,209/18614,0.018923503,0.071067823,0.039271311,SFRP1/AXIN2,2
GO:0000028,ribosomal small subunit assembly, 1/19,19/18614,0.019226078,0.071067823,0.039271311,RPL38,1
GO:0016553,base conversion or substitution editing, 1/19,19/18614,0.019226078,0.071067823,0.039271311,ADAR,1
GO:0034244,negative regulation of transcription elongation by RNA polymerase II, 1/19,19/18614,0.019226078,0.071067823,0.039271311,HNRNPU,1
GO:0035372,protein localization to microtubule, 1/19,19/18614,0.019226078,0.071067823,0.039271311,HNRNPU,1
GO:0043628,regulatory ncRNA 3'-end processing, 1/19,19/18614,0.019226078,0.071067823,0.039271311,FBL,1
GO:0046782,regulation of viral transcription, 1/19,19/18614,0.019226078,0.071067823,0.039271311,DHX9,1
GO:0070242,thymocyte apoptotic process, 1/19,19/18614,0.019226078,0.071067823,0.039271311,HIF1A,1
GO:1901522,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus, 1/19,19/18614,0.019226078,0.071067823,0.039271311,HIF1A,1
GO:1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway, 1/19,19/18614,0.019226078,0.071067823,0.039271311,HIF1A,1
GO:2000434,regulation of protein neddylation, 1/19,19/18614,0.019226078,0.071067823,0.039271311,HIF1A,1
GO:0030705,cytoskeleton-dependent intracellular transport, 2/19,212/18614,0.019436716,0.071210624,0.039350222,HNRNPU/HIF1A,2
GO:0045619,regulation of lymphocyte differentiation, 2/19,212/18614,0.019436716,0.071210624,0.039350222,SFRP1/RUNX1,2
GO:0099111,microtubule-based transport, 2/19,212/18614,0.019436716,0.071210624,0.039350222,HNRNPU/HIF1A,2
GO:0031396,regulation of protein ubiquitination, 2/19,213/18614,0.019609098,0.071576753,0.039552541,GTPBP4/SIRT7,2
GO:0032211,negative regulation of telomere maintenance via telomerase, 1/19,20/18614,0.020228213,0.071576753,0.039552541,HNRNPU,1
GO:0042474,middle ear morphogenesis, 1/19,20/18614,0.020228213,0.071576753,0.039552541,RPL38,1
GO:0060216,definitive hemopoiesis, 1/19,20/18614,0.020228213,0.071576753,0.039552541,ADAR,1
GO:0060339,negative regulation of type I interferon-mediated signaling pathway, 1/19,20/18614,0.020228213,0.071576753,0.039552541,ADAR,1
GO:0060749,mammary gland alveolus development, 1/19,20/18614,0.020228213,0.071576753,0.039552541,HIF1A,1
GO:0061377,mammary gland lobule development, 1/19,20/18614,0.020228213,0.071576753,0.039552541,HIF1A,1
GO:0070314,G1 to G0 transition, 1/19,20/18614,0.020228213,0.071576753,0.039552541,MYBBP1A,1
GO:0071379,cellular response to prostaglandin stimulus, 1/19,20/18614,0.020228213,0.071576753,0.039552541,SFRP1,1
GO:0097284,hepatocyte apoptotic process, 1/19,20/18614,0.020228213,0.071576753,0.039552541,ADAR,1
GO:2000269,regulation of fibroblast apoptotic process, 1/19,20/18614,0.020228213,0.071576753,0.039552541,SFRP1,1
GO:2001185,"regulation of CD8-positive, alpha-beta T cell activation", 1/19,20/18614,0.020228213,0.071576753,0.039552541,RUNX1,1
GO:0006469,negative regulation of protein kinase activity, 2/19,217/18614,0.020305144,0.071644854,0.039590173,SFRP1/ADAR,2
GO:0015931,nucleobase-containing compound transport, 2/19,221/18614,0.021011552,0.073445369,0.040585118,DHX9/ALYREF,2
GO:0002888,positive regulation of myeloid leukocyte mediated immunity, 1/19,21/18614,0.021229378,0.073445369,0.040585118,DDX21,1
GO:0030502,negative regulation of bone mineralization, 1/19,21/18614,0.021229378,0.073445369,0.040585118,HIF1A,1
GO:0042790,nucleolar large rRNA transcription by RNA polymerase I, 1/19,21/18614,0.021229378,0.073445369,0.040585118,SIRT7,1
GO:0045821,positive regulation of glycolytic process, 1/19,21/18614,0.021229378,0.073445369,0.040585118,HIF1A,1
GO:0051315,attachment of mitotic spindle microtubules to kinetochore, 1/19,21/18614,0.021229378,0.073445369,0.040585118,HNRNPU,1
GO:1903204,negative regulation of oxidative stress-induced neuron death, 1/19,21/18614,0.021229378,0.073445369,0.040585118,HIF1A,1
GO:0050679,positive regulation of epithelial cell proliferation, 2/19,225/18614,0.021728237,0.074561654,0.041201965,SFRP1/HIF1A,2
GO:0050866,negative regulation of cell activation, 2/19,225/18614,0.021728237,0.074561654,0.041201965,SFRP1/RUNX1,2
GO:0002573,myeloid leukocyte differentiation, 2/19,227/18614,0.022090406,0.074561654,0.041201965,SFRP1/RUNX1,2
GO:0000470,maturation of LSU-rRNA, 1/19,22/18614,0.022229574,0.074561654,0.041201965,GTPBP4,1
GO:0032785,"negative regulation of DNA-templated transcription, elongation", 1/19,22/18614,0.022229574,0.074561654,0.041201965,HNRNPU,1
GO:0034104,negative regulation of tissue remodeling, 1/19,22/18614,0.022229574,0.074561654,0.041201965,SFRP1,1
GO:0043371,"negative regulation of CD4-positive, alpha-beta T cell differentiation", 1/19,22/18614,0.022229574,0.074561654,0.041201965,RUNX1,1
GO:0046597,negative regulation of viral entry into host cell, 1/19,22/18614,0.022229574,0.074561654,0.041201965,IFITM1,1
GO:0048025,"negative regulation of mRNA splicing, via spliceosome", 1/19,22/18614,0.022229574,0.074561654,0.041201965,RBMX,1
GO:0051000,positive regulation of nitric-oxide synthase activity, 1/19,22/18614,0.022229574,0.074561654,0.041201965,HIF1A,1
GO:0071359,cellular response to dsRNA, 1/19,22/18614,0.022229574,0.074561654,0.041201965,DHX9,1
GO:0019318,hexose metabolic process, 2/19,228/18614,0.022272443,0.074561654,0.041201965,SIRT7/IGFBP3,2
GO:0048705,skeletal system morphogenesis, 2/19,229/18614,0.022455112,0.074971099,0.04142822,SFRP1/AXIN2,2
GO:0031669,cellular response to nutrient levels, 2/19,230/18614,0.022638413,0.075380452,0.041654424,MYBBP1A/SFRP1,2
GO:0002070,epithelial cell maturation, 1/19,23/18614,0.023228801,0.075921503,0.041953403,HIF1A,1
GO:0006353,DNA-templated transcription termination, 1/19,23/18614,0.023228801,0.075921503,0.041953403,DHX9,1
GO:0032727,positive regulation of interferon-alpha production, 1/19,23/18614,0.023228801,0.075921503,0.041953403,DHX9,1
GO:0046716,muscle cell cellular homeostasis, 1/19,23/18614,0.023228801,0.075921503,0.041953403,HIF1A,1
GO:0051457,maintenance of protein location in nucleus, 1/19,23/18614,0.023228801,0.075921503,0.041953403,HNRNPU,1
GO:0071305,cellular response to vitamin D, 1/19,23/18614,0.023228801,0.075921503,0.041953403,SFRP1,1
GO:1901673,regulation of mitotic spindle assembly, 1/19,23/18614,0.023228801,0.075921503,0.041953403,HNRNPU,1
GO:0071356,cellular response to tumor necrosis factor, 2/19,235/18614,0.023564344,0.076816049,0.042447719,DHX9/SFRP1,2
GO:0030072,peptide hormone secretion, 2/19,238/18614,0.024127395,0.076956548,0.042525358,SFRP1/HIF1A,2
GO:0014850,response to muscle activity, 1/19,24/18614,0.024227061,0.076956548,0.042525358,HIF1A,1
GO:0034695,response to prostaglandin E, 1/19,24/18614,0.024227061,0.076956548,0.042525358,SFRP1,1
GO:0035162,embryonic hemopoiesis, 1/19,24/18614,0.024227061,0.076956548,0.042525358,HIF1A,1
GO:0050686,negative regulation of mRNA processing, 1/19,24/18614,0.024227061,0.076956548,0.042525358,RBMX,1
GO:0060571,morphogenesis of an epithelial fold, 1/19,24/18614,0.024227061,0.076956548,0.042525358,HIF1A,1
GO:0061484,hematopoietic stem cell homeostasis, 1/19,24/18614,0.024227061,0.076956548,0.042525358,ADAR,1
GO:0070233,negative regulation of T cell apoptotic process, 1/19,24/18614,0.024227061,0.076956548,0.042525358,HIF1A,1
GO:0090335,regulation of brown fat cell differentiation, 1/19,24/18614,0.024227061,0.076956548,0.042525358,HNRNPU,1
GO:0140747,regulation of ncRNA transcription, 1/19,24/18614,0.024227061,0.076956548,0.042525358,SIRT7,1
GO:0002790,peptide secretion, 2/19,243/18614,0.02507819,0.078517917,0.043388153,SFRP1/HIF1A,2
GO:0045333,cellular respiration, 2/19,243/18614,0.02507819,0.078517917,0.043388153,MYBBP1A/HIF1A,2
GO:0048738,cardiac muscle tissue development, 2/19,243/18614,0.02507819,0.078517917,0.043388153,HNRNPU/RUNX1,2
GO:0000027,ribosomal large subunit assembly, 1/19,25/18614,0.025224355,0.078517917,0.043388153,RPL38,1
GO:0003181,atrioventricular valve morphogenesis, 1/19,25/18614,0.025224355,0.078517917,0.043388153,AXIN2,1
GO:0043567,regulation of insulin-like growth factor receptor signaling pathway, 1/19,25/18614,0.025224355,0.078517917,0.043388153,IGFBP3,1
GO:0046885,regulation of hormone biosynthetic process, 1/19,25/18614,0.025224355,0.078517917,0.043388153,HIF1A,1
GO:2000209,regulation of anoikis, 1/19,25/18614,0.025224355,0.078517917,0.043388153,MYBBP1A,1
GO:0046883,regulation of hormone secretion, 2/19,247/18614,0.025849867,0.079680398,0.044030528,SFRP1/HIF1A,2
GO:0031639,plasminogen activation, 1/19,26/18614,0.026220683,0.079680398,0.044030528,RUNX1,1
GO:0044346,fibroblast apoptotic process, 1/19,26/18614,0.026220683,0.079680398,0.044030528,SFRP1,1
GO:0051894,positive regulation of focal adhesion assembly, 1/19,26/18614,0.026220683,0.079680398,0.044030528,SFRP1,1
GO:0060343,trabecula formation, 1/19,26/18614,0.026220683,0.079680398,0.044030528,SFRP1,1
GO:0060575,intestinal epithelial cell differentiation, 1/19,26/18614,0.026220683,0.079680398,0.044030528,HIF1A,1
GO:0060740,prostate gland epithelium morphogenesis, 1/19,26/18614,0.026220683,0.079680398,0.044030528,SFRP1,1
GO:1903901,negative regulation of viral life cycle, 1/19,26/18614,0.026220683,0.079680398,0.044030528,IFITM1,1
GO:2000050,regulation of non-canonical Wnt signaling pathway, 1/19,26/18614,0.026220683,0.079680398,0.044030528,SFRP1,1
GO:0033002,muscle cell proliferation, 2/19,249/18614,0.026239358,0.079680398,0.044030528,RUNX1/IGFBP3,2
GO:0033044,regulation of chromosome organization, 2/19,250/18614,0.026435012,0.079883905,0.044142983,HNRNPU/AXIN2,2
GO:0043543,protein acylation, 2/19,250/18614,0.026435012,0.079883905,0.044142983,MYBBP1A/DDX21,2
GO:0045926,negative regulation of growth, 2/19,252/18614,0.02682813,0.079910943,0.044157924,SFRP1/HIF1A,2
GO:0031167,rRNA methylation, 1/19,27/18614,0.027216046,0.079910943,0.044157924,FBL,1
GO:0032967,positive regulation of collagen biosynthetic process, 1/19,27/18614,0.027216046,0.079910943,0.044157924,RUNX1,1
GO:0033119,negative regulation of RNA splicing, 1/19,27/18614,0.027216046,0.079910943,0.044157924,RBMX,1
GO:0034643,"establishment of mitochondrion localization, microtubule-mediated", 1/19,27/18614,0.027216046,0.079910943,0.044157924,HIF1A,1
GO:0046639,negative regulation of alpha-beta T cell differentiation, 1/19,27/18614,0.027216046,0.079910943,0.044157924,RUNX1,1
GO:0047497,mitochondrion transport along microtubule, 1/19,27/18614,0.027216046,0.079910943,0.044157924,HIF1A,1
GO:0051984,positive regulation of chromosome segregation, 1/19,27/18614,0.027216046,0.079910943,0.044157924,HNRNPU,1
GO:0071549,cellular response to dexamethasone stimulus, 1/19,27/18614,0.027216046,0.079910943,0.044157924,AXIN2,1
GO:1904357,negative regulation of telomere maintenance via telomere lengthening, 1/19,27/18614,0.027216046,0.079910943,0.044157924,HNRNPU,1
GO:2000737,negative regulation of stem cell differentiation, 1/19,27/18614,0.027216046,0.079910943,0.044157924,HNRNPU,1
GO:2001032,regulation of double-strand break repair via nonhomologous end joining, 1/19,27/18614,0.027216046,0.079910943,0.044157924,SIRT7,1
GO:0005996,monosaccharide metabolic process, 2/19,256/18614,0.027621572,0.080029371,0.044223366,SIRT7/IGFBP3,2
GO:0034612,response to tumor necrosis factor, 2/19,257/18614,0.027821427,0.080029371,0.044223366,DHX9/SFRP1,2
GO:0003171,atrioventricular valve development, 1/19,28/18614,0.028210445,0.080029371,0.044223366,AXIN2,1
GO:0003401,axis elongation, 1/19,28/18614,0.028210445,0.080029371,0.044223366,SFRP1,1
GO:0010528,regulation of transposition, 1/19,28/18614,0.028210445,0.080029371,0.044223366,SIRT7,1
GO:0010529,negative regulation of transposition, 1/19,28/18614,0.028210445,0.080029371,0.044223366,SIRT7,1
GO:0010714,positive regulation of collagen metabolic process, 1/19,28/18614,0.028210445,0.080029371,0.044223366,RUNX1,1
GO:0036037,"CD8-positive, alpha-beta T cell activation", 1/19,28/18614,0.028210445,0.080029371,0.044223366,RUNX1,1
GO:0045116,protein neddylation, 1/19,28/18614,0.028210445,0.080029371,0.044223366,HIF1A,1
GO:0060512,prostate gland morphogenesis, 1/19,28/18614,0.028210445,0.080029371,0.044223366,SFRP1,1
GO:0060765,regulation of androgen receptor signaling pathway, 1/19,28/18614,0.028210445,0.080029371,0.044223366,SFRP1,1
GO:0070269,pyroptosis, 1/19,28/18614,0.028210445,0.080029371,0.044223366,DHX9,1
GO:1903055,positive regulation of extracellular matrix organization, 1/19,28/18614,0.028210445,0.080029371,0.044223366,RUNX1,1
GO:0014706,striated muscle tissue development, 2/19,259/18614,0.028222918,0.080029371,0.044223366,HNRNPU/RUNX1,2
GO:0015833,peptide transport, 2/19,259/18614,0.028222918,0.080029371,0.044223366,SFRP1/HIF1A,2
GO:0060828,regulation of canonical Wnt signaling pathway, 2/19,260/18614,0.028424553,0.080417529,0.044437858,SFRP1/AXIN2,2
GO:0031668,cellular response to extracellular stimulus, 2/19,261/18614,0.028626779,0.08080559,0.044652297,MYBBP1A/SFRP1,2
GO:0003007,heart morphogenesis, 2/19,262/18614,0.028829595,0.080962544,0.044739028,HIF1A/AXIN2,2
GO:0002052,positive regulation of neuroblast proliferation, 1/19,29/18614,0.029203881,0.080962544,0.044739028,HIF1A,1
GO:0010458,exit from mitosis, 1/19,29/18614,0.029203881,0.080962544,0.044739028,SIRT7,1
GO:0010575,positive regulation of vascular endothelial growth factor production, 1/19,29/18614,0.029203881,0.080962544,0.044739028,HIF1A,1
GO:0032607,interferon-alpha production, 1/19,29/18614,0.029203881,0.080962544,0.044739028,DHX9,1
GO:0032647,regulation of interferon-alpha production, 1/19,29/18614,0.029203881,0.080962544,0.044739028,DHX9,1
GO:1900017,positive regulation of cytokine production involved in inflammatory response, 1/19,29/18614,0.029203881,0.080962544,0.044739028,HIF1A,1
GO:1902175,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway, 1/19,29/18614,0.029203881,0.080962544,0.044739028,HIF1A,1
GO:0009048,dosage compensation by inactivation of X chromosome, 1/19,30/18614,0.030196355,0.083157145,0.04595174,HNRNPU,1
GO:0035774,positive regulation of insulin secretion involved in cellular response to glucose stimulus, 1/19,30/18614,0.030196355,0.083157145,0.04595174,HIF1A,1
GO:0070168,negative regulation of biomineral tissue development, 1/19,30/18614,0.030196355,0.083157145,0.04595174,HIF1A,1
GO:0090596,sensory organ morphogenesis, 2/19,269/18614,0.030265711,0.083163746,0.045955388,RPL38/HIF1A,2
GO:0010039,response to iron ion, 1/19,31/18614,0.031187867,0.084852647,0.046888657,HIF1A,1
GO:0051654,establishment of mitochondrion localization, 1/19,31/18614,0.031187867,0.084852647,0.046888657,HIF1A,1
GO:0150117,positive regulation of cell-substrate junction organization, 1/19,31/18614,0.031187867,0.084852647,0.046888657,SFRP1,1
GO:1903203,regulation of oxidative stress-induced neuron death, 1/19,31/18614,0.031187867,0.084852647,0.046888657,HIF1A,1
GO:0050708,regulation of protein secretion, 2/19,275/18614,0.031519288,0.084852647,0.046888657,SFRP1/HIF1A,2
GO:0061448,connective tissue development, 2/19,275/18614,0.031519288,0.084852647,0.046888657,HIF1A/AXIN2,2
GO:0006298,mismatch repair, 1/19,32/18614,0.032178419,0.084852647,0.046888657,AXIN2,1
GO:0007549,dosage compensation, 1/19,32/18614,0.032178419,0.084852647,0.046888657,HNRNPU,1
GO:0008156,negative regulation of DNA replication, 1/19,32/18614,0.032178419,0.084852647,0.046888657,GTPBP4,1
GO:0010165,response to X-ray, 1/19,32/18614,0.032178419,0.084852647,0.046888657,SFRP1,1
GO:0032196,transposition, 1/19,32/18614,0.032178419,0.084852647,0.046888657,SIRT7,1
GO:0032770,positive regulation of monooxygenase activity, 1/19,32/18614,0.032178419,0.084852647,0.046888657,HIF1A,1
GO:0034694,response to prostaglandin, 1/19,32/18614,0.032178419,0.084852647,0.046888657,SFRP1,1
GO:0035456,response to interferon-beta, 1/19,32/18614,0.032178419,0.084852647,0.046888657,IFITM1,1
GO:0045070,positive regulation of viral genome replication, 1/19,32/18614,0.032178419,0.084852647,0.046888657,ADAR,1
GO:0045671,negative regulation of osteoclast differentiation, 1/19,32/18614,0.032178419,0.084852647,0.046888657,SFRP1,1
GO:0046825,regulation of protein export from nucleus, 1/19,32/18614,0.032178419,0.084852647,0.046888657,SIRT7,1
GO:0048026,"positive regulation of mRNA splicing, via spliceosome", 1/19,32/18614,0.032178419,0.084852647,0.046888657,RBMX,1
GO:0071295,cellular response to vitamin, 1/19,32/18614,0.032178419,0.084852647,0.046888657,SFRP1,1
GO:0002063,chondrocyte development, 1/19,33/18614,0.033168012,0.086543426,0.047822963,AXIN2,1
GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway, 1/19,33/18614,0.033168012,0.086543426,0.047822963,HIF1A,1
GO:0048147,negative regulation of fibroblast proliferation, 1/19,33/18614,0.033168012,0.086543426,0.047822963,SFRP1,1
GO:0090169,regulation of spindle assembly, 1/19,33/18614,0.033168012,0.086543426,0.047822963,HNRNPU,1
GO:1903715,regulation of aerobic respiration, 1/19,33/18614,0.033168012,0.086543426,0.047822963,HIF1A,1
GO:0010721,negative regulation of cell development, 2/19,286/18614,0.033870806,0.086931463,0.048037388,SFRP1/RUNX1,2
GO:0140014,mitotic nuclear division, 2/19,286/18614,0.033870806,0.086931463,0.048037388,HNRNPU/SIRT7,2
GO:0001782,B cell homeostasis, 1/19,34/18614,0.034156646,0.086931463,0.048037388,HIF1A,1
GO:0032743,positive regulation of interleukin-2 production, 1/19,34/18614,0.034156646,0.086931463,0.048037388,RUNX1,1
GO:0036475,neuron death in response to oxidative stress, 1/19,34/18614,0.034156646,0.086931463,0.048037388,HIF1A,1
GO:0045577,regulation of B cell differentiation, 1/19,34/18614,0.034156646,0.086931463,0.048037388,SFRP1,1
GO:0045648,positive regulation of erythrocyte differentiation, 1/19,34/18614,0.034156646,0.086931463,0.048037388,HIF1A,1
GO:0050869,negative regulation of B cell activation, 1/19,34/18614,0.034156646,0.086931463,0.048037388,SFRP1,1
GO:0060351,cartilage development involved in endochondral bone morphogenesis, 1/19,34/18614,0.034156646,0.086931463,0.048037388,AXIN2,1
GO:0060914,heart formation, 1/19,34/18614,0.034156646,0.086931463,0.048037388,AXIN2,1
GO:0060964,regulation of miRNA-mediated gene silencing, 1/19,34/18614,0.034156646,0.086931463,0.048037388,DHX9,1
GO:2000515,"negative regulation of CD4-positive, alpha-beta T cell activation", 1/19,34/18614,0.034156646,0.086931463,0.048037388,RUNX1,1
GO:0044262,cellular carbohydrate metabolic process, 2/19,290/18614,0.034742741,0.088242299,0.048761741,SIRT7/IGFBP3,2
GO:0032205,negative regulation of telomere maintenance, 1/19,35/18614,0.035144322,0.088538028,0.048925158,HNRNPU,1
GO:0043276,anoikis, 1/19,35/18614,0.035144322,0.088538028,0.048925158,MYBBP1A,1
GO:0061081,positive regulation of myeloid leukocyte cytokine production involved in immune response, 1/19,35/18614,0.035144322,0.088538028,0.048925158,DDX21,1
GO:0071425,hematopoietic stem cell proliferation, 1/19,35/18614,0.035144322,0.088538028,0.048925158,RUNX1,1
GO:0001666,response to hypoxia, 2/19,293/18614,0.035402507,0.089007924,0.049184818,SFRP1/HIF1A,2
GO:0048562,embryonic organ morphogenesis, 2/19,294/18614,0.035623531,0.089382678,0.049391902,RPL38/HIF1A,2
GO:0000154,rRNA modification, 1/19,36/18614,0.036131041,0.089929365,0.049693996,FBL,1
GO:0002068,glandular epithelial cell development, 1/19,36/18614,0.036131041,0.089929365,0.049693996,HIF1A,1
GO:0060218,hematopoietic stem cell differentiation, 1/19,36/18614,0.036131041,0.089929365,0.049693996,SFRP1,1
GO:1903580,positive regulation of ATP metabolic process, 1/19,36/18614,0.036131041,0.089929365,0.049693996,HIF1A,1
GO:0009303,rRNA transcription, 1/19,37/18614,0.037116805,0.091274693,0.05043741,SIRT7,1
GO:0010092,specification of animal organ identity, 1/19,37/18614,0.037116805,0.091274693,0.05043741,AXIN2,1
GO:0033144,negative regulation of intracellular steroid hormone receptor signaling pathway, 1/19,37/18614,0.037116805,0.091274693,0.05043741,SFRP1,1
GO:0033280,response to vitamin D, 1/19,37/18614,0.037116805,0.091274693,0.05043741,SFRP1,1
GO:1903146,regulation of autophagy of mitochondrion, 1/19,37/18614,0.037116805,0.091274693,0.05043741,HIF1A,1
GO:2000279,negative regulation of DNA biosynthetic process, 1/19,37/18614,0.037116805,0.091274693,0.05043741,HNRNPU,1
GO:0097193,intrinsic apoptotic signaling pathway, 2/19,301/18614,0.037185986,0.091274693,0.05043741,MYBBP1A/HIF1A,2
GO:0048872,homeostasis of number of cells, 2/19,304/18614,0.037863734,0.092066543,0.050874978,HIF1A/ADAR,2
GO:0046879,hormone secretion, 2/19,305/18614,0.038090725,0.092066543,0.050874978,SFRP1/HIF1A,2
GO:0003180,aortic valve morphogenesis, 1/19,38/18614,0.038101613,0.092066543,0.050874978,AXIN2,1
GO:0032728,positive regulation of interferon-beta production, 1/19,38/18614,0.038101613,0.092066543,0.050874978,DHX9,1
GO:0043618,regulation of transcription from RNA polymerase II promoter in response to stress, 1/19,38/18614,0.038101613,0.092066543,0.050874978,HIF1A,1
GO:0045880,positive regulation of smoothened signaling pathway, 1/19,38/18614,0.038101613,0.092066543,0.050874978,SFRP1,1
GO:0046676,negative regulation of insulin secretion, 1/19,38/18614,0.038101613,0.092066543,0.050874978,SFRP1,1
GO:0070229,negative regulation of lymphocyte apoptotic process, 1/19,38/18614,0.038101613,0.092066543,0.050874978,HIF1A,1
GO:0036293,response to decreased oxygen levels, 2/19,306/18614,0.038318251,0.092410228,0.051064894,SFRP1/HIF1A,2
GO:0030851,granulocyte differentiation, 1/19,39/18614,0.039085467,0.093354134,0.051586486,RUNX1,1
GO:0032350,regulation of hormone metabolic process, 1/19,39/18614,0.039085467,0.093354134,0.051586486,HIF1A,1
GO:0045740,positive regulation of DNA replication, 1/19,39/18614,0.039085467,0.093354134,0.051586486,DHX9,1
GO:0046329,negative regulation of JNK cascade, 1/19,39/18614,0.039085467,0.093354134,0.051586486,SFRP1,1
GO:0070232,regulation of T cell apoptotic process, 1/19,39/18614,0.039085467,0.093354134,0.051586486,HIF1A,1
GO:0007162,negative regulation of cell adhesion, 2/19,312/18614,0.039694579,0.094626999,0.052289858,GTPBP4/RUNX1,2
GO:0044403,biological process involved in symbiotic interaction, 2/19,313/18614,0.039925817,0.094790308,0.052380101,IFITM1/ALYREF,2
GO:0060070,canonical Wnt signaling pathway, 2/19,313/18614,0.039925817,0.094790308,0.052380101,SFRP1/AXIN2,2
GO:0071392,cellular response to estradiol stimulus, 1/19,40/18614,0.040068367,0.094790308,0.052380101,SFRP1,1
GO:0071634,regulation of transforming growth factor beta production, 1/19,40/18614,0.040068367,0.094790308,0.052380101,HIF1A,1
GO:0030198,extracellular matrix organization, 2/19,314/18614,0.040157582,0.094820754,0.052396925,RUNX1/AXIN2,2
GO:0009914,hormone transport, 2/19,315/18614,0.040389871,0.095007992,0.052500391,SFRP1/HIF1A,2
GO:0043062,extracellular structure organization, 2/19,315/18614,0.040389871,0.095007992,0.052500391,RUNX1/AXIN2,2
GO:0045229,external encapsulating structure organization, 2/19,317/18614,0.040856018,0.095655706,0.05285831,RUNX1/AXIN2,2
GO:0032965,regulation of collagen biosynthetic process, 1/19,41/18614,0.041050315,0.095655706,0.05285831,RUNX1,1
GO:0050685,positive regulation of mRNA processing, 1/19,41/18614,0.041050315,0.095655706,0.05285831,RBMX,1
GO:0072595,maintenance of protein localization in organelle, 1/19,41/18614,0.041050315,0.095655706,0.05285831,HNRNPU,1
GO:1902275,regulation of chromatin organization, 1/19,41/18614,0.041050315,0.095655706,0.05285831,HNRNPU,1
GO:1902105,regulation of leukocyte differentiation, 2/19,319/18614,0.041324248,0.096113701,0.053111393,SFRP1/RUNX1,2
GO:0019058,viral life cycle, 2/19,320/18614,0.041559142,0.096137916,0.053124775,IFITM1/ADAR,2
GO:0007595,lactation, 1/19,42/18614,0.042031311,0.096137916,0.053124775,HIF1A,1
GO:0014912,negative regulation of smooth muscle cell migration, 1/19,42/18614,0.042031311,0.096137916,0.053124775,IGFBP3,1
GO:0045292,"mRNA cis splicing, via spliceosome", 1/19,42/18614,0.042031311,0.096137916,0.053124775,SNRNP200,1
GO:0045981,positive regulation of nucleotide metabolic process, 1/19,42/18614,0.042031311,0.096137916,0.053124775,HIF1A,1
GO:0050691,regulation of defense response to virus by host, 1/19,42/18614,0.042031311,0.096137916,0.053124775,DHX9,1
GO:0050999,regulation of nitric-oxide synthase activity, 1/19,42/18614,0.042031311,0.096137916,0.053124775,HIF1A,1
GO:0060338,regulation of type I interferon-mediated signaling pathway, 1/19,42/18614,0.042031311,0.096137916,0.053124775,ADAR,1
GO:1900544,positive regulation of purine nucleotide metabolic process, 1/19,42/18614,0.042031311,0.096137916,0.053124775,HIF1A,1
GO:0003176,aortic valve development, 1/19,43/18614,0.043011357,0.096775553,0.053477126,AXIN2,1
GO:0008608,attachment of spindle microtubules to kinetochore, 1/19,43/18614,0.043011357,0.096775553,0.053477126,HNRNPU,1
GO:0010719,negative regulation of epithelial to mesenchymal transition, 1/19,43/18614,0.043011357,0.096775553,0.053477126,SFRP1,1
GO:0031670,cellular response to nutrient, 1/19,43/18614,0.043011357,0.096775553,0.053477126,SFRP1,1
GO:0045663,positive regulation of myoblast differentiation, 1/19,43/18614,0.043011357,0.096775553,0.053477126,IGFBP3,1
GO:0060236,regulation of mitotic spindle organization, 1/19,43/18614,0.043011357,0.096775553,0.053477126,HNRNPU,1
GO:0071548,response to dexamethasone, 1/19,43/18614,0.043011357,0.096775553,0.053477126,AXIN2,1
GO:0071604,transforming growth factor beta production, 1/19,43/18614,0.043011357,0.096775553,0.053477126,HIF1A,1
GO:0090278,negative regulation of peptide hormone secretion, 1/19,43/18614,0.043011357,0.096775553,0.053477126,SFRP1,1
GO:0071496,cellular response to external stimulus, 2/19,327/18614,0.043217818,0.097064249,0.053636656,MYBBP1A/SFRP1,2
GO:0002792,negative regulation of peptide secretion, 1/19,44/18614,0.043990452,0.098266442,0.054300975,SFRP1,1
GO:0006509,membrane protein ectodomain proteolysis, 1/19,44/18614,0.043990452,0.098266442,0.054300975,RBMX,1
GO:0043620,regulation of DNA-templated transcription in response to stress, 1/19,44/18614,0.043990452,0.098266442,0.054300975,HIF1A,1
GO:0032386,regulation of intracellular transport, 2/19,332/18614,0.044417886,0.099043113,0.054730155,SIRT7/DHX9,2
GO:0070482,response to oxygen levels, 2/19,333/18614,0.044659414,0.099379003,0.054915764,SFRP1/HIF1A,2
GO:0060562,epithelial tube morphogenesis, 2/19,334/18614,0.044901444,0.099379003,0.054915764,SFRP1/HIF1A,2
GO:0008631,intrinsic apoptotic signaling pathway in response to oxidative stress, 1/19,45/18614,0.044968599,0.099379003,0.054915764,HIF1A,1
GO:0046636,negative regulation of alpha-beta T cell activation, 1/19,45/18614,0.044968599,0.099379003,0.054915764,RUNX1,1
GO:1902692,regulation of neuroblast proliferation, 1/19,45/18614,0.044968599,0.099379003,0.054915764,HIF1A,1
GO:0015980,energy derivation by oxidation of organic compounds, 2/19,337/18614,0.045630538,0.100465986,0.055516419,MYBBP1A/HIF1A,2
GO:0030111,regulation of Wnt signaling pathway, 2/19,338/18614,0.045874565,0.100465986,0.055516419,SFRP1/AXIN2,2
GO:0010712,regulation of collagen metabolic process, 1/19,46/18614,0.045945797,0.100465986,0.055516419,RUNX1,1
GO:0031297,replication fork processing, 1/19,46/18614,0.045945797,0.100465986,0.055516419,ALYREF,1
GO:0033120,positive regulation of RNA splicing, 1/19,46/18614,0.045945797,0.100465986,0.055516419,RBMX,1
GO:2000273,positive regulation of signaling receptor activity, 1/19,46/18614,0.045945797,0.100465986,0.055516419,HIF1A,1
GO:0098813,nuclear chromosome segregation, 2/19,339/18614,0.04611909,0.100667679,0.055627873,HNRNPU/SIRT7,2
GO:0030521,androgen receptor signaling pathway, 1/19,47/18614,0.046922048,0.101351625,0.056005813,SFRP1,1
GO:0035196,miRNA processing, 1/19,47/18614,0.046922048,0.101351625,0.056005813,ADAR,1
GO:0045646,regulation of erythrocyte differentiation, 1/19,47/18614,0.046922048,0.101351625,0.056005813,HIF1A,1
GO:0061383,trabecula morphogenesis, 1/19,47/18614,0.046922048,0.101351625,0.056005813,SFRP1,1
GO:0090224,regulation of spindle organization, 1/19,47/18614,0.046922048,0.101351625,0.056005813,HNRNPU,1
GO:1905314,semi-lunar valve development, 1/19,47/18614,0.046922048,0.101351625,0.056005813,AXIN2,1
GO:0090287,regulation of cellular response to growth factor stimulus, 2/19,345/18614,0.047596597,0.102566401,0.056677086,SFRP1/HIF1A,2
GO:0006110,regulation of glycolytic process, 1/19,48/18614,0.047897353,0.102566401,0.056677086,HIF1A,1
GO:0008542,visual learning, 1/19,48/18614,0.047897353,0.102566401,0.056677086,HIF1A,1
GO:0030850,prostate gland development, 1/19,48/18614,0.047897353,0.102566401,0.056677086,SFRP1,1
GO:0046596,regulation of viral entry into host cell, 1/19,48/18614,0.047897353,0.102566401,0.056677086,IFITM1,1
GO:0042886,amide transport, 2/19,349/18614,0.048591386,0.103873496,0.057399372,SFRP1/HIF1A,2
GO:0042149,cellular response to glucose starvation, 1/19,49/18614,0.048871712,0.103936073,0.057433951,MYBBP1A,1
GO:0046850,regulation of bone remodeling, 1/19,49/18614,0.048871712,0.103936073,0.057433951,SFRP1,1
GO:0060043,regulation of cardiac muscle cell proliferation, 1/19,49/18614,0.048871712,0.103936073,0.057433951,RUNX1,1
GO:0002066,columnar/cuboidal epithelial cell development, 1/19,50/18614,0.049845126,0.104928215,0.057982199,HIF1A,1
GO:0043457,regulation of cellular respiration, 1/19,50/18614,0.049845126,0.104928215,0.057982199,HIF1A,1
GO:0045581,negative regulation of T cell differentiation, 1/19,50/18614,0.049845126,0.104928215,0.057982199,RUNX1,1
GO:0048009,insulin-like growth factor receptor signaling pathway, 1/19,50/18614,0.049845126,0.104928215,0.057982199,IGFBP3,1
GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors, 1/19,50/18614,0.049845126,0.104928215,0.057982199,SFRP1,1
GO:2000378,negative regulation of reactive oxygen species metabolic process, 1/19,50/18614,0.049845126,0.104928215,0.057982199,HIF1A,1
GO:0006111,regulation of gluconeogenesis, 1/19,51/18614,0.050817597,0.105017397,0.058031479,SIRT7,1
GO:0019083,viral transcription, 1/19,51/18614,0.050817597,0.105017397,0.058031479,DHX9,1
GO:0032873,negative regulation of stress-activated MAPK cascade, 1/19,51/18614,0.050817597,0.105017397,0.058031479,SFRP1,1
GO:0032964,collagen biosynthetic process, 1/19,51/18614,0.050817597,0.105017397,0.058031479,RUNX1,1
GO:0051646,mitochondrion localization, 1/19,51/18614,0.050817597,0.105017397,0.058031479,HIF1A,1
GO:0060688,regulation of morphogenesis of a branching structure, 1/19,51/18614,0.050817597,0.105017397,0.058031479,SFRP1,1
GO:0061082,myeloid leukocyte cytokine production, 1/19,51/18614,0.050817597,0.105017397,0.058031479,DDX21,1
GO:0061178,regulation of insulin secretion involved in cellular response to glucose stimulus, 1/19,51/18614,0.050817597,0.105017397,0.058031479,HIF1A,1
GO:0070303,negative regulation of stress-activated protein kinase signaling cascade, 1/19,51/18614,0.050817597,0.105017397,0.058031479,SFRP1,1
GO:1902895,positive regulation of miRNA transcription, 1/19,51/18614,0.050817597,0.105017397,0.058031479,HIF1A,1
GO:2001238,positive regulation of extrinsic apoptotic signaling pathway, 1/19,51/18614,0.050817597,0.105017397,0.058031479,SFRP1,1
GO:0002762,negative regulation of myeloid leukocyte differentiation, 1/19,52/18614,0.051789124,0.106493531,0.058847175,SFRP1,1
GO:0046638,positive regulation of alpha-beta T cell differentiation, 1/19,52/18614,0.051789124,0.106493531,0.058847175,RUNX1,1
GO:0051496,positive regulation of stress fiber assembly, 1/19,52/18614,0.051789124,0.106493531,0.058847175,SFRP1,1
GO:0007129,homologous chromosome pairing at meiosis, 1/19,53/18614,0.05275971,0.107246415,0.059263211,SIRT7,1
GO:0032210,regulation of telomere maintenance via telomerase, 1/19,53/18614,0.05275971,0.107246415,0.059263211,HNRNPU,1
GO:0033047,regulation of mitotic sister chromatid segregation, 1/19,53/18614,0.05275971,0.107246415,0.059263211,HNRNPU,1
GO:0048146,positive regulation of fibroblast proliferation, 1/19,53/18614,0.05275971,0.107246415,0.059263211,DHX9,1
GO:0050873,brown fat cell differentiation, 1/19,53/18614,0.05275971,0.107246415,0.059263211,HNRNPU,1
GO:0060071,"Wnt signaling pathway, planar cell polarity pathway", 1/19,53/18614,0.05275971,0.107246415,0.059263211,SFRP1,1
GO:2000648,positive regulation of stem cell proliferation, 1/19,53/18614,0.05275971,0.107246415,0.059263211,HNRNPU,1
GO:0051098,regulation of binding, 2/19,369/18614,0.053680036,0.108155361,0.059765485,GTPBP4/DHX9,2
GO:0071900,regulation of protein serine/threonine kinase activity, 2/19,369/18614,0.053680036,0.108155361,0.059765485,GTPBP4/SFRP1,2
GO:0007632,visual behavior, 1/19,54/18614,0.053729354,0.108155361,0.059765485,HIF1A,1
GO:0032330,regulation of chondrocyte differentiation, 1/19,54/18614,0.053729354,0.108155361,0.059765485,AXIN2,1
GO:0072698,protein localization to microtubule cytoskeleton, 1/19,54/18614,0.053729354,0.108155361,0.059765485,HNRNPU,1
GO:2000179,positive regulation of neural precursor cell proliferation, 1/19,54/18614,0.053729354,0.108155361,0.059765485,HIF1A,1
GO:0043370,"regulation of CD4-positive, alpha-beta T cell differentiation", 1/19,55/18614,0.054698058,0.109264467,0.060378365,RUNX1,1
GO:0052372,modulation by symbiont of entry into host, 1/19,55/18614,0.054698058,0.109264467,0.060378365,IFITM1,1
GO:1903202,negative regulation of oxidative stress-induced cell death, 1/19,55/18614,0.054698058,0.109264467,0.060378365,HIF1A,1
GO:0009306,protein secretion, 2/19,373/18614,0.054720208,0.109264467,0.060378365,SFRP1/HIF1A,2
GO:0045088,regulation of innate immune response, 2/19,373/18614,0.054720208,0.109264467,0.060378365,DHX9/ADAR,2
GO:0035592,establishment of protein localization to extracellular region, 2/19,374/18614,0.054981397,0.109609783,0.060569183,SFRP1/HIF1A,2
GO:0001954,positive regulation of cell-matrix adhesion, 1/19,56/18614,0.055665822,0.109741192,0.060641798,SFRP1,1
GO:0032608,interferon-beta production, 1/19,56/18614,0.055665822,0.109741192,0.060641798,DHX9,1
GO:0032648,regulation of interferon-beta production, 1/19,56/18614,0.055665822,0.109741192,0.060641798,DHX9,1
GO:0045005,DNA-templated DNA replication maintenance of fidelity, 1/19,56/18614,0.055665822,0.109741192,0.060641798,ALYREF,1
GO:0045071,negative regulation of viral genome replication, 1/19,56/18614,0.055665822,0.109741192,0.060641798,IFITM1,1
GO:0070231,T cell apoptotic process, 1/19,56/18614,0.055665822,0.109741192,0.060641798,HIF1A,1
GO:2000107,negative regulation of leukocyte apoptotic process, 1/19,56/18614,0.055665822,0.109741192,0.060641798,HIF1A,1
GO:0007080,mitotic metaphase plate congression, 1/19,57/18614,0.056632648,0.110942821,0.061305805,HNRNPU,1
GO:0032768,regulation of monooxygenase activity, 1/19,57/18614,0.056632648,0.110942821,0.061305805,HIF1A,1
GO:0043470,regulation of carbohydrate catabolic process, 1/19,57/18614,0.056632648,0.110942821,0.061305805,HIF1A,1
GO:0090175,regulation of establishment of planar polarity, 1/19,57/18614,0.056632648,0.110942821,0.061305805,SFRP1,1
GO:2001233,regulation of apoptotic signaling pathway, 2/19,381/18614,0.05682243,0.111139303,0.061414379,SFRP1/HIF1A,2
GO:0071692,protein localization to extracellular region, 2/19,382/18614,0.057087237,0.11148168,0.061603573,SFRP1/HIF1A,2
GO:0001755,neural crest cell migration, 1/19,58/18614,0.057598536,0.111602779,0.06167049,HIF1A,1
GO:0010718,positive regulation of epithelial to mesenchymal transition, 1/19,58/18614,0.057598536,0.111602779,0.06167049,AXIN2,1
GO:0044380,protein localization to cytoskeleton, 1/19,58/18614,0.057598536,0.111602779,0.06167049,HNRNPU,1
GO:0048010,vascular endothelial growth factor receptor signaling pathway, 1/19,58/18614,0.057598536,0.111602779,0.06167049,HIF1A,1
GO:0050732,negative regulation of peptidyl-tyrosine phosphorylation, 1/19,58/18614,0.057598536,0.111602779,0.06167049,SFRP1,1
GO:0001961,positive regulation of cytokine-mediated signaling pathway, 1/19,59/18614,0.058563486,0.112246682,0.062026305,HIF1A,1
GO:0002763,positive regulation of myeloid leukocyte differentiation, 1/19,59/18614,0.058563486,0.112246682,0.062026305,RUNX1,1
GO:0006611,protein export from nucleus, 1/19,59/18614,0.058563486,0.112246682,0.062026305,SIRT7,1
GO:0007062,sister chromatid cohesion, 1/19,59/18614,0.058563486,0.112246682,0.062026305,AXIN2,1
GO:0010574,regulation of vascular endothelial growth factor production, 1/19,59/18614,0.058563486,0.112246682,0.062026305,HIF1A,1
GO:0033619,membrane protein proteolysis, 1/19,59/18614,0.058563486,0.112246682,0.062026305,RBMX,1
GO:0070228,regulation of lymphocyte apoptotic process, 1/19,59/18614,0.058563486,0.112246682,0.062026305,HIF1A,1
GO:0140694,non-membrane-bounded organelle assembly, 2/19,390/18614,0.059221716,0.11236042,0.062089155,HNRNPU/RPL38,2
GO:0002886,regulation of myeloid leukocyte mediated immunity, 1/19,60/18614,0.059527501,0.11236042,0.062089155,DDX21,1
GO:0003179,heart valve morphogenesis, 1/19,60/18614,0.059527501,0.11236042,0.062089155,AXIN2,1
GO:0032007,negative regulation of TOR signaling, 1/19,60/18614,0.059527501,0.11236042,0.062089155,HIF1A,1
GO:0042255,ribosome assembly, 1/19,60/18614,0.059527501,0.11236042,0.062089155,RPL38,1
GO:0043407,negative regulation of MAP kinase activity, 1/19,60/18614,0.059527501,0.11236042,0.062089155,SFRP1,1
GO:0046824,positive regulation of nucleocytoplasmic transport, 1/19,60/18614,0.059527501,0.11236042,0.062089155,DHX9,1
GO:0060350,endochondral bone morphogenesis, 1/19,60/18614,0.059527501,0.11236042,0.062089155,AXIN2,1
GO:0090497,mesenchymal cell migration, 1/19,60/18614,0.059527501,0.11236042,0.062089155,HIF1A,1
GO:2000630,positive regulation of miRNA metabolic process, 1/19,60/18614,0.059527501,0.11236042,0.062089155,HIF1A,1
GO:0032786,"positive regulation of DNA-templated transcription, elongation", 1/19,61/18614,0.060490581,0.113317196,0.062617859,ALYREF,1
GO:0035773,insulin secretion involved in cellular response to glucose stimulus, 1/19,61/18614,0.060490581,0.113317196,0.062617859,HIF1A,1
GO:0043903,regulation of biological process involved in symbiotic interaction, 1/19,61/18614,0.060490581,0.113317196,0.062617859,IFITM1,1
GO:0060038,cardiac muscle cell proliferation, 1/19,61/18614,0.060490581,0.113317196,0.062617859,RUNX1,1
GO:1904356,regulation of telomere maintenance via telomere lengthening, 1/19,61/18614,0.060490581,0.113317196,0.062617859,HNRNPU,1
GO:0032233,positive regulation of actin filament bundle assembly, 1/19,62/18614,0.061452726,0.114429214,0.063232348,SFRP1,1
GO:0032481,positive regulation of type I interferon production, 1/19,62/18614,0.061452726,0.114429214,0.063232348,DHX9,1
GO:0043506,regulation of JUN kinase activity, 1/19,62/18614,0.061452726,0.114429214,0.063232348,SFRP1,1
GO:1904036,negative regulation of epithelial cell apoptotic process, 1/19,62/18614,0.061452726,0.114429214,0.063232348,ADAR,1
GO:0010573,vascular endothelial growth factor production, 1/19,63/18614,0.062413937,0.115354331,0.063743558,HIF1A,1
GO:0031638,zymogen activation, 1/19,63/18614,0.062413937,0.115354331,0.063743558,RUNX1,1
GO:0032623,interleukin-2 production, 1/19,63/18614,0.062413937,0.115354331,0.063743558,RUNX1,1
GO:0032663,regulation of interleukin-2 production, 1/19,63/18614,0.062413937,0.115354331,0.063743558,RUNX1,1
GO:0051353,positive regulation of oxidoreductase activity, 1/19,63/18614,0.062413937,0.115354331,0.063743558,HIF1A,1
GO:0006303,double-strand break repair via nonhomologous end joining, 1/19,64/18614,0.063374216,0.11643606,0.06434131,SIRT7,1
GO:0045143,homologous chromosome segregation, 1/19,64/18614,0.063374216,0.11643606,0.06434131,SIRT7,1
GO:0051893,regulation of focal adhesion assembly, 1/19,64/18614,0.063374216,0.11643606,0.06434131,SFRP1,1
GO:0090109,regulation of cell-substrate junction assembly, 1/19,64/18614,0.063374216,0.11643606,0.06434131,SFRP1,1
GO:0001947,heart looping, 1/19,65/18614,0.064333564,0.116987241,0.064645886,HIF1A,1
GO:0006879,intracellular iron ion homeostasis, 1/19,65/18614,0.064333564,0.116987241,0.064645886,HIF1A,1
GO:0032507,maintenance of protein location in cell, 1/19,65/18614,0.064333564,0.116987241,0.064645886,HNRNPU,1
GO:0046888,negative regulation of hormone secretion, 1/19,65/18614,0.064333564,0.116987241,0.064645886,SFRP1,1
GO:0098781,ncRNA transcription, 1/19,65/18614,0.064333564,0.116987241,0.064645886,SIRT7,1
GO:0098930,axonal transport, 1/19,65/18614,0.064333564,0.116987241,0.064645886,HIF1A,1
GO:1905330,regulation of morphogenesis of an epithelium, 1/19,65/18614,0.064333564,0.116987241,0.064645886,SFRP1,1
GO:0001655,urogenital system development, 1/19,66/18614,0.06529198,0.11855649,0.065513036,SFRP1,1
GO:0042446,hormone biosynthetic process, 1/19,67/18614,0.066249466,0.119944368,0.066279963,HIF1A,1
GO:0070613,regulation of protein processing, 1/19,67/18614,0.066249466,0.119944368,0.066279963,RUNX1,1
GO:0007018,microtubule-based movement, 2/19,417/18614,0.066629799,0.120100547,0.066366266,HNRNPU/HIF1A,2
GO:0050678,regulation of epithelial cell proliferation, 2/19,419/18614,0.067190704,0.120100547,0.066366266,SFRP1/HIF1A,2
GO:0006406,mRNA export from nucleus, 1/19,68/18614,0.067206023,0.120100547,0.066366266,ALYREF,1
GO:0035019,somatic stem cell population maintenance, 1/19,68/18614,0.067206023,0.120100547,0.066366266,SFRP1,1
GO:0045670,regulation of osteoclast differentiation, 1/19,68/18614,0.067206023,0.120100547,0.066366266,SFRP1,1
GO:0048645,animal organ formation, 1/19,68/18614,0.067206023,0.120100547,0.066366266,AXIN2,1
GO:0055021,regulation of cardiac muscle tissue growth, 1/19,68/18614,0.067206023,0.120100547,0.066366266,RUNX1,1
GO:0061180,mammary gland epithelium development, 1/19,68/18614,0.067206023,0.120100547,0.066366266,HIF1A,1
GO:1902893,regulation of miRNA transcription, 1/19,68/18614,0.067206023,0.120100547,0.066366266,HIF1A,1
GO:0001558,regulation of cell growth, 2/19,420/18614,0.067471771,0.120402211,0.066532962,SFRP1/IGFBP3,2
GO:0030098,lymphocyte differentiation, 2/19,422/18614,0.068035125,0.120938244,0.066829168,SFRP1/RUNX1,2
GO:0007004,telomere maintenance via telomerase, 1/19,69/18614,0.068161651,0.120938244,0.066829168,HNRNPU,1
GO:0061614,miRNA transcription, 1/19,69/18614,0.068161651,0.120938244,0.066829168,HIF1A,1
GO:0150116,regulation of cell-substrate junction organization, 1/19,69/18614,0.068161651,0.120938244,0.066829168,SFRP1,1
GO:0014823,response to activity, 1/19,70/18614,0.069116352,0.121678512,0.067238232,HIF1A,1
GO:0030514,negative regulation of BMP signaling pathway, 1/19,70/18614,0.069116352,0.121678512,0.067238232,SFRP1,1
GO:0032722,positive regulation of chemokine production, 1/19,70/18614,0.069116352,0.121678512,0.067238232,HIF1A,1
GO:0043627,response to estrogen, 1/19,70/18614,0.069116352,0.121678512,0.067238232,SFRP1,1
GO:0061371,determination of heart left/right asymmetry, 1/19,70/18614,0.069116352,0.121678512,0.067238232,HIF1A,1
GO:0060537,muscle tissue development, 2/19,426/18614,0.069166691,0.121678512,0.067238232,HNRNPU/RUNX1,2
GO:0003143,embryonic heart tube morphogenesis, 1/19,71/18614,0.070070126,0.122573376,0.067732724,HIF1A,1
GO:0003208,cardiac ventricle morphogenesis, 1/19,71/18614,0.070070126,0.122573376,0.067732724,HIF1A,1
GO:0070918,regulatory ncRNA processing, 1/19,71/18614,0.070070126,0.122573376,0.067732724,ADAR,1
GO:1903317,regulation of protein maturation, 1/19,71/18614,0.070070126,0.122573376,0.067732724,RUNX1,1
GO:0010720,positive regulation of cell development, 2/19,432/18614,0.070876063,0.123199071,0.068078476,RUNX1/HIF1A,2
GO:0002260,lymphocyte homeostasis, 1/19,72/18614,0.071022975,0.123199071,0.068078476,HIF1A,1
GO:0033143,regulation of intracellular steroid hormone receptor signaling pathway, 1/19,72/18614,0.071022975,0.123199071,0.068078476,SFRP1,1
GO:0046635,positive regulation of alpha-beta T cell activation, 1/19,72/18614,0.071022975,0.123199071,0.068078476,RUNX1,1
GO:0051310,metaphase plate congression, 1/19,72/18614,0.071022975,0.123199071,0.068078476,HNRNPU,1
GO:0090307,mitotic spindle assembly, 1/19,72/18614,0.071022975,0.123199071,0.068078476,HNRNPU,1
GO:0007059,chromosome segregation, 2/19,435/18614,0.0717361,0.123641526,0.068322972,HNRNPU/SIRT7,2
GO:0003170,heart valve development, 1/19,73/18614,0.071974898,0.123641526,0.068322972,AXIN2,1
GO:0007405,neuroblast proliferation, 1/19,73/18614,0.071974898,0.123641526,0.068322972,HIF1A,1
GO:0035567,non-canonical Wnt signaling pathway, 1/19,73/18614,0.071974898,0.123641526,0.068322972,SFRP1,1
GO:0042246,tissue regeneration, 1/19,73/18614,0.071974898,0.123641526,0.068322972,RUNX1,1
GO:0046637,regulation of alpha-beta T cell differentiation, 1/19,73/18614,0.071974898,0.123641526,0.068322972,RUNX1,1
GO:0061035,regulation of cartilage development, 1/19,73/18614,0.071974898,0.123641526,0.068322972,AXIN2,1
GO:0001736,establishment of planar polarity, 1/19,74/18614,0.072925897,0.124244121,0.06865596,SFRP1,1
GO:0002067,glandular epithelial cell differentiation, 1/19,74/18614,0.072925897,0.124244121,0.06865596,HIF1A,1
GO:0007164,establishment of tissue polarity, 1/19,74/18614,0.072925897,0.124244121,0.06865596,SFRP1,1
GO:0045661,regulation of myoblast differentiation, 1/19,74/18614,0.072925897,0.124244121,0.06865596,IGFBP3,1
GO:0060420,regulation of heart growth, 1/19,74/18614,0.072925897,0.124244121,0.06865596,RUNX1,1
GO:1903578,regulation of ATP metabolic process, 1/19,74/18614,0.072925897,0.124244121,0.06865596,HIF1A,1
GO:0048732,gland development, 2/19,441/18614,0.073466743,0.124327858,0.068702232,SFRP1/HIF1A,2
GO:0006278,RNA-templated DNA biosynthetic process, 1/19,75/18614,0.073875973,0.124327858,0.068702232,HNRNPU,1
GO:0010822,positive regulation of mitochondrion organization, 1/19,75/18614,0.073875973,0.124327858,0.068702232,HIF1A,1
GO:0016239,positive regulation of macroautophagy, 1/19,75/18614,0.073875973,0.124327858,0.068702232,HIF1A,1
GO:0043536,positive regulation of blood vessel endothelial cell migration, 1/19,75/18614,0.073875973,0.124327858,0.068702232,HIF1A,1
GO:0045669,positive regulation of osteoblast differentiation, 1/19,75/18614,0.073875973,0.124327858,0.068702232,IFITM1,1
GO:0048662,negative regulation of smooth muscle cell proliferation, 1/19,75/18614,0.073875973,0.124327858,0.068702232,IGFBP3,1
GO:0070192,chromosome organization involved in meiotic cell cycle, 1/19,75/18614,0.073875973,0.124327858,0.068702232,SIRT7,1
GO:0071479,cellular response to ionizing radiation, 1/19,75/18614,0.073875973,0.124327858,0.068702232,SFRP1,1
GO:0051656,establishment of organelle localization, 2/19,445/18614,0.074628246,0.125423926,0.069307907,HNRNPU/HIF1A,2
GO:0007422,peripheral nervous system development, 1/19,76/18614,0.074825127,0.125584875,0.069396846,RUNX1,1
GO:0032508,DNA duplex unwinding, 1/19,77/18614,0.075773359,0.126833573,0.070086863,DHX9,1
GO:2000514,"regulation of CD4-positive, alpha-beta T cell activation", 1/19,77/18614,0.075773359,0.126833573,0.070086863,RUNX1,1
GO:0000280,nuclear division, 2/19,450/18614,0.076088723,0.127049429,0.070206143,HNRNPU/SIRT7,2
GO:0009314,response to radiation, 2/19,452/18614,0.076675563,0.127049429,0.070206143,SFRP1/HIF1A,2
GO:0002200,somatic diversification of immune receptors, 1/19,78/18614,0.07672067,0.127049429,0.070206143,ADAR,1
GO:0002534,cytokine production involved in inflammatory response, 1/19,78/18614,0.07672067,0.127049429,0.070206143,HIF1A,1
GO:0042274,ribosomal small subunit biogenesis, 1/19,78/18614,0.07672067,0.127049429,0.070206143,RPL38,1
GO:0045824,negative regulation of innate immune response, 1/19,78/18614,0.07672067,0.127049429,0.070206143,ADAR,1
GO:0050709,negative regulation of protein secretion, 1/19,78/18614,0.07672067,0.127049429,0.070206143,SFRP1,1
GO:1900015,regulation of cytokine production involved in inflammatory response, 1/19,78/18614,0.07672067,0.127049429,0.070206143,HIF1A,1
GO:0048568,embryonic organ development, 2/19,453/18614,0.076969547,0.127291848,0.070340101,RPL38/HIF1A,2
GO:0045913,positive regulation of carbohydrate metabolic process, 1/19,79/18614,0.077667061,0.127764887,0.070601497,HIF1A,1
GO:0050688,regulation of defense response to virus, 1/19,79/18614,0.077667061,0.127764887,0.070601497,DHX9,1
GO:1903201,regulation of oxidative stress-induced cell death, 1/19,79/18614,0.077667061,0.127764887,0.070601497,HIF1A,1
GO:2000736,regulation of stem cell differentiation, 1/19,79/18614,0.077667061,0.127764887,0.070601497,HNRNPU,1
GO:0002720,positive regulation of cytokine production involved in immune response, 1/19,80/18614,0.078612533,0.128808399,0.07117813,DDX21,1
GO:0030500,regulation of bone mineralization, 1/19,80/18614,0.078612533,0.128808399,0.07117813,HIF1A,1
GO:0070227,lymphocyte apoptotic process, 1/19,80/18614,0.078612533,0.128808399,0.07117813,HIF1A,1
GO:0016055,Wnt signaling pathway, 2/19,461/18614,0.079334824,0.129671788,0.07165523,SFRP1/AXIN2,2
GO:0010833,telomere maintenance via telomere lengthening, 1/19,81/18614,0.079557087,0.129671788,0.07165523,HNRNPU,1
GO:0014855,striated muscle cell proliferation, 1/19,81/18614,0.079557087,0.129671788,0.07165523,RUNX1,1
GO:2000628,regulation of miRNA metabolic process, 1/19,81/18614,0.079557087,0.129671788,0.07165523,HIF1A,1
GO:0002831,regulation of response to biotic stimulus, 2/19,463/18614,0.079929831,0.129938285,0.071802493,DHX9/ADAR,2
GO:0198738,cell-cell signaling by wnt, 2/19,463/18614,0.079929831,0.129938285,0.071802493,SFRP1/AXIN2,2
GO:0003151,outflow tract morphogenesis, 1/19,82/18614,0.080500724,0.130524672,0.072126524,HIF1A,1
GO:0014032,neural crest cell development, 1/19,82/18614,0.080500724,0.130524672,0.072126524,HIF1A,1
GO:0032024,positive regulation of insulin secretion, 1/19,83/18614,0.081443443,0.131538045,0.072686504,HIF1A,1
GO:0032392,DNA geometric change, 1/19,83/18614,0.081443443,0.131538045,0.072686504,DHX9,1
GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator, 1/19,83/18614,0.081443443,0.131538045,0.072686504,MYBBP1A,1
GO:0006094,gluconeogenesis, 1/19,84/18614,0.082385248,0.132713979,0.073336312,SIRT7,1
GO:0051303,establishment of chromosome localization, 1/19,84/18614,0.082385248,0.132713979,0.073336312,HNRNPU,1
GO:1903131,mononuclear cell differentiation, 2/19,474/18614,0.083228257,0.133536855,0.073791024,SFRP1/RUNX1,2
GO:0006096,glycolytic process, 1/19,85/18614,0.083326137,0.133536855,0.073791024,HIF1A,1
GO:0035050,embryonic heart tube development, 1/19,85/18614,0.083326137,0.133536855,0.073791024,HIF1A,1
GO:0055013,cardiac muscle cell development, 1/19,85/18614,0.083326137,0.133536855,0.073791024,HNRNPU,1
GO:0031667,response to nutrient levels, 2/19,477/18614,0.084135324,0.134177579,0.074145081,MYBBP1A/SFRP1,2
GO:0006757,ATP generation from ADP, 1/19,86/18614,0.084266112,0.134177579,0.074145081,HIF1A,1
GO:0008306,associative learning, 1/19,86/18614,0.084266112,0.134177579,0.074145081,HIF1A,1
GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors, 1/19,86/18614,0.084266112,0.134177579,0.074145081,SFRP1,1
GO:0048041,focal adhesion assembly, 1/19,86/18614,0.084266112,0.134177579,0.074145081,SFRP1,1
GO:0001960,negative regulation of cytokine-mediated signaling pathway, 1/19,87/18614,0.085205175,0.134980647,0.074588848,ADAR,1
GO:0008589,regulation of smoothened signaling pathway, 1/19,87/18614,0.085205175,0.134980647,0.074588848,SFRP1,1
GO:0019319,hexose biosynthetic process, 1/19,87/18614,0.085205175,0.134980647,0.074588848,SIRT7,1
GO:0034243,regulation of transcription elongation by RNA polymerase II, 1/19,87/18614,0.085205175,0.134980647,0.074588848,HNRNPU,1
GO:0045785,positive regulation of cell adhesion, 2/19,482/18614,0.085654122,0.135519006,0.074886339,SFRP1/RUNX1,2
GO:0023061,signal release, 2/19,483/18614,0.085958926,0.135602039,0.074932223,SFRP1/HIF1A,2
GO:0033273,response to vitamin, 1/19,88/18614,0.086143324,0.135602039,0.074932223,SFRP1,1
GO:0046849,bone remodeling, 1/19,88/18614,0.086143324,0.135602039,0.074932223,SFRP1,1
GO:0048864,stem cell development, 1/19,88/18614,0.086143324,0.135602039,0.074932223,HIF1A,1
GO:0001892,embryonic placenta development, 1/19,89/18614,0.087080563,0.13621418,0.075270485,HIF1A,1
GO:0007589,body fluid secretion, 1/19,89/18614,0.087080563,0.13621418,0.075270485,HIF1A,1
GO:0043367,"CD4-positive, alpha-beta T cell differentiation", 1/19,89/18614,0.087080563,0.13621418,0.075270485,RUNX1,1
GO:0055072,iron ion homeostasis, 1/19,89/18614,0.087080563,0.13621418,0.075270485,HIF1A,1
GO:2000177,regulation of neural precursor cell proliferation, 1/19,89/18614,0.087080563,0.13621418,0.075270485,HIF1A,1
GO:0001510,RNA methylation, 1/19,90/18614,0.08801689,0.136817244,0.075603732,FBL,1
GO:0014910,regulation of smooth muscle cell migration, 1/19,90/18614,0.08801689,0.136817244,0.075603732,IGFBP3,1
GO:0048525,negative regulation of viral process, 1/19,90/18614,0.08801689,0.136817244,0.075603732,IFITM1,1
GO:0071103,DNA conformation change, 1/19,90/18614,0.08801689,0.136817244,0.075603732,DHX9,1
GO:2000106,regulation of leukocyte apoptotic process, 1/19,90/18614,0.08801689,0.136817244,0.075603732,HIF1A,1
GO:0022407,regulation of cell-cell adhesion, 2/19,491/18614,0.088409738,0.137149173,0.075787152,GTPBP4/RUNX1,2
GO:0001843,neural tube closure, 1/19,91/18614,0.088952308,0.137149173,0.075787152,SFRP1,1
GO:0030901,midbrain development, 1/19,91/18614,0.088952308,0.137149173,0.075787152,SFRP1,1
GO:0070098,chemokine-mediated signaling pathway, 1/19,91/18614,0.088952308,0.137149173,0.075787152,HIF1A,1
GO:0072091,regulation of stem cell proliferation, 1/19,91/18614,0.088952308,0.137149173,0.075787152,HNRNPU,1
GO:0072384,organelle transport along microtubule, 1/19,91/18614,0.088952308,0.137149173,0.075787152,HIF1A,1
GO:0016049,cell growth, 2/19,495/18614,0.089643298,0.137149173,0.075787152,SFRP1/IGFBP3,2
GO:0000422,autophagy of mitochondrion, 1/19,92/18614,0.089886817,0.137149173,0.075787152,HIF1A,1
GO:0045185,maintenance of protein location, 1/19,92/18614,0.089886817,0.137149173,0.075787152,HNRNPU,1
GO:0050000,chromosome localization, 1/19,92/18614,0.089886817,0.137149173,0.075787152,HNRNPU,1
GO:0055006,cardiac cell development, 1/19,92/18614,0.089886817,0.137149173,0.075787152,HNRNPU,1
GO:0055017,cardiac muscle tissue growth, 1/19,92/18614,0.089886817,0.137149173,0.075787152,RUNX1,1
GO:0060606,tube closure, 1/19,92/18614,0.089886817,0.137149173,0.075787152,SFRP1,1
GO:0060761,negative regulation of response to cytokine stimulus, 1/19,92/18614,0.089886817,0.137149173,0.075787152,ADAR,1
GO:0061726,mitochondrion disassembly, 1/19,92/18614,0.089886817,0.137149173,0.075787152,HIF1A,1
GO:0048285,organelle fission, 2/19,497/18614,0.090262092,0.137552783,0.076010183,HNRNPU/SIRT7,2
GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process, 1/19,93/18614,0.090820418,0.137896037,0.076199861,AXIN2,1
GO:1900542,regulation of purine nucleotide metabolic process, 1/19,93/18614,0.090820418,0.137896037,0.076199861,HIF1A,1
GO:2001251,negative regulation of chromosome organization, 1/19,93/18614,0.090820418,0.137896037,0.076199861,HNRNPU,1
GO:0000245,spliceosomal complex assembly, 1/19,94/18614,0.091753111,0.138130138,0.076329223,SNRNP200,1
GO:0001738,morphogenesis of a polarized epithelium, 1/19,94/18614,0.091753111,0.138130138,0.076329223,SFRP1,1
GO:0006140,regulation of nucleotide metabolic process, 1/19,94/18614,0.091753111,0.138130138,0.076329223,HIF1A,1
GO:0016575,histone deacetylation, 1/19,94/18614,0.091753111,0.138130138,0.076329223,SIRT7,1
GO:0046031,ADP metabolic process, 1/19,94/18614,0.091753111,0.138130138,0.076329223,HIF1A,1
GO:0051492,regulation of stress fiber assembly, 1/19,94/18614,0.091753111,0.138130138,0.076329223,SFRP1,1
GO:1900407,regulation of cellular response to oxidative stress, 1/19,94/18614,0.091753111,0.138130138,0.076329223,HIF1A,1
GO:0045638,negative regulation of myeloid cell differentiation, 1/19,95/18614,0.092684898,0.139363974,0.077011027,SFRP1,1
GO:0007044,cell-substrate junction assembly, 1/19,96/18614,0.093615779,0.140423668,0.077596603,SFRP1,1
GO:0046364,monosaccharide biosynthetic process, 1/19,96/18614,0.093615779,0.140423668,0.077596603,SIRT7,1
GO:0001657,ureteric bud development, 1/19,97/18614,0.094545755,0.141306652,0.07808453,SFRP1,1
GO:0010586,miRNA metabolic process, 1/19,97/18614,0.094545755,0.141306652,0.07808453,HIF1A,1
GO:0014909,smooth muscle cell migration, 1/19,97/18614,0.094545755,0.141306652,0.07808453,IGFBP3,1
GO:0032642,regulation of chemokine production, 1/19,98/18614,0.095474827,0.142011659,0.078474109,HIF1A,1
GO:0072163,mesonephric epithelium development, 1/19,98/18614,0.095474827,0.142011659,0.078474109,SFRP1,1
GO:0072164,mesonephric tubule development, 1/19,98/18614,0.095474827,0.142011659,0.078474109,SFRP1,1
GO:0097306,cellular response to alcohol, 1/19,98/18614,0.095474827,0.142011659,0.078474109,SFRP1,1
GO:0032602,chemokine production, 1/19,99/18614,0.096402996,0.142369229,0.078671699,HIF1A,1
GO:0036473,cell death in response to oxidative stress, 1/19,99/18614,0.096402996,0.142369229,0.078671699,HIF1A,1
GO:0060349,bone morphogenesis, 1/19,99/18614,0.096402996,0.142369229,0.078671699,AXIN2,1
GO:1990868,response to chemokine, 1/19,99/18614,0.096402996,0.142369229,0.078671699,HIF1A,1
GO:1990869,cellular response to chemokine, 1/19,99/18614,0.096402996,0.142369229,0.078671699,HIF1A,1
GO:2001243,negative regulation of intrinsic apoptotic signaling pathway, 1/19,99/18614,0.096402996,0.142369229,0.078671699,HIF1A,1
GO:0019080,viral gene expression, 1/19,100/18614,0.097330263,0.143227709,0.079146086,DHX9,1
GO:0032755,positive regulation of interleukin-6 production, 1/19,100/18614,0.097330263,0.143227709,0.079146086,DHX9,1
GO:0060419,heart growth, 1/19,100/18614,0.097330263,0.143227709,0.079146086,RUNX1,1
GO:0043255,regulation of carbohydrate biosynthetic process, 1/19,101/18614,0.098256628,0.144249092,0.079710491,SIRT7,1
GO:0070167,regulation of biomineral tissue development, 1/19,101/18614,0.098256628,0.144249092,0.079710491,HIF1A,1
GO:0001823,mesonephros development, 1/19,102/18614,0.099182093,0.144412848,0.07980098,SFRP1,1
GO:0002532,production of molecular mediator involved in inflammatory response, 1/19,102/18614,0.099182093,0.144412848,0.07980098,HIF1A,1
GO:0006165,nucleoside diphosphate phosphorylation, 1/19,102/18614,0.099182093,0.144412848,0.07980098,HIF1A,1
GO:0008585,female gonad development, 1/19,102/18614,0.099182093,0.144412848,0.07980098,SFRP1,1
GO:0030316,osteoclast differentiation, 1/19,102/18614,0.099182093,0.144412848,0.07980098,SFRP1,1
GO:0046620,regulation of organ growth, 1/19,102/18614,0.099182093,0.144412848,0.07980098,RUNX1,1
GO:1990830,cellular response to leukemia inhibitory factor, 1/19,102/18614,0.099182093,0.144412848,0.07980098,HNRNPU,1
GO:0001776,leukocyte homeostasis, 1/19,103/18614,0.100106657,0.144909637,0.080075501,HIF1A,1
GO:0031123,RNA 3'-end processing, 1/19,103/18614,0.100106657,0.144909637,0.080075501,FBL,1
GO:0150115,cell-substrate junction organization, 1/19,103/18614,0.100106657,0.144909637,0.080075501,SFRP1,1
GO:1902882,regulation of response to oxidative stress, 1/19,103/18614,0.100106657,0.144909637,0.080075501,HIF1A,1
GO:1990823,response to leukemia inhibitory factor, 1/19,103/18614,0.100106657,0.144909637,0.080075501,HNRNPU,1
GO:0032204,regulation of telomere maintenance, 1/19,104/18614,0.101030323,0.145231089,0.080253132,HNRNPU,1
GO:0032479,regulation of type I interferon production, 1/19,104/18614,0.101030323,0.145231089,0.080253132,DHX9,1
GO:0032606,type I interferon production, 1/19,104/18614,0.101030323,0.145231089,0.080253132,DHX9,1
GO:0033045,regulation of sister chromatid segregation, 1/19,104/18614,0.101030323,0.145231089,0.080253132,HNRNPU,1
GO:0046939,nucleotide phosphorylation, 1/19,104/18614,0.101030323,0.145231089,0.080253132,HIF1A,1
GO:0110020,regulation of actomyosin structure organization, 1/19,104/18614,0.101030323,0.145231089,0.080253132,SFRP1,1
GO:0032760,positive regulation of tumor necrosis factor production, 1/19,105/18614,0.10195309,0.146388136,0.080892504,DHX9,1
GO:0009135,purine nucleoside diphosphate metabolic process, 1/19,106/18614,0.10287496,0.147031876,0.081248227,HIF1A,1
GO:0009179,purine ribonucleoside diphosphate metabolic process, 1/19,106/18614,0.10287496,0.147031876,0.081248227,HIF1A,1
GO:0046545,development of primary female sexual characteristics, 1/19,106/18614,0.10287496,0.147031876,0.081248227,SFRP1,1
GO:1901890,positive regulation of cell junction assembly, 1/19,106/18614,0.10287496,0.147031876,0.081248227,SFRP1,1
GO:0090277,positive regulation of peptide hormone secretion, 1/19,107/18614,0.103795934,0.148177643,0.081881366,HIF1A,1
GO:0032231,regulation of actin filament bundle assembly, 1/19,108/18614,0.104716011,0.149319502,0.082512344,SFRP1,1
GO:0002793,positive regulation of peptide secretion, 1/19,109/18614,0.105635194,0.14959967,0.082667163,HIF1A,1
GO:0030038,contractile actin filament bundle assembly, 1/19,109/18614,0.105635194,0.14959967,0.082667163,SFRP1,1
GO:0043149,stress fiber assembly, 1/19,109/18614,0.105635194,0.14959967,0.082667163,SFRP1,1
GO:0045132,meiotic chromosome segregation, 1/19,109/18614,0.105635194,0.14959967,0.082667163,SIRT7,1
GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production, 1/19,109/18614,0.105635194,0.14959967,0.082667163,DHX9,1
GO:1904035,regulation of epithelial cell apoptotic process, 1/19,109/18614,0.105635194,0.14959967,0.082667163,ADAR,1
GO:0002444,myeloid leukocyte mediated immunity, 1/19,110/18614,0.106553483,0.1500447,0.082913081,DDX21,1
GO:0006368,transcription elongation by RNA polymerase II, 1/19,110/18614,0.106553483,0.1500447,0.082913081,HNRNPU,1
GO:0014812,muscle cell migration, 1/19,110/18614,0.106553483,0.1500447,0.082913081,IGFBP3,1
GO:0045445,myoblast differentiation, 1/19,110/18614,0.106553483,0.1500447,0.082913081,IGFBP3,1
GO:0090263,positive regulation of canonical Wnt signaling pathway, 1/19,110/18614,0.106553483,0.1500447,0.082913081,SFRP1,1
GO:0051341,regulation of oxidoreductase activity, 1/19,111/18614,0.107470878,0.150994152,0.083437738,HIF1A,1
GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process, 1/19,111/18614,0.107470878,0.150994152,0.083437738,AXIN2,1
GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity, 1/19,112/18614,0.108387381,0.151938067,0.083959335,GTPBP4,1
GO:0006090,pyruvate metabolic process, 1/19,112/18614,0.108387381,0.151938067,0.083959335,HIF1A,1
GO:0044344,cellular response to fibroblast growth factor stimulus, 1/19,113/18614,0.109302992,0.153048835,0.084573133,SFRP1,1
GO:0046634,regulation of alpha-beta T cell activation, 1/19,114/18614,0.110217713,0.154155855,0.085184861,RUNX1,1
GO:0001938,positive regulation of endothelial cell proliferation, 1/19,115/18614,0.111131543,0.154910636,0.085601945,HIF1A,1
GO:0030518,intracellular steroid hormone receptor signaling pathway, 1/19,115/18614,0.111131543,0.154910636,0.085601945,SFRP1,1
GO:0035710,"CD4-positive, alpha-beta T cell activation", 1/19,115/18614,0.111131543,0.154910636,0.085601945,RUNX1,1
GO:0006476,protein deacetylation, 1/19,116/18614,0.112044484,0.155138517,0.085727869,SIRT7,1
GO:0009185,ribonucleoside diphosphate metabolic process, 1/19,116/18614,0.112044484,0.155138517,0.085727869,HIF1A,1
GO:0032006,regulation of TOR signaling, 1/19,116/18614,0.112044484,0.155138517,0.085727869,HIF1A,1
GO:0045582,positive regulation of T cell differentiation, 1/19,116/18614,0.112044484,0.155138517,0.085727869,RUNX1,1
GO:0071346,cellular response to type II interferon, 1/19,116/18614,0.112044484,0.155138517,0.085727869,SYNCRIP,1
GO:1904029,regulation of cyclin-dependent protein kinase activity, 1/19,116/18614,0.112044484,0.155138517,0.085727869,GTPBP4,1
GO:0071887,leukocyte apoptotic process, 1/19,117/18614,0.112956537,0.156053414,0.086233432,HIF1A,1
GO:1901800,positive regulation of proteasomal protein catabolic process, 1/19,117/18614,0.112956537,0.156053414,0.086233432,AXIN2,1
GO:0002065,columnar/cuboidal epithelial cell differentiation, 1/19,118/18614,0.113867703,0.156963026,0.086736073,HIF1A,1
GO:0030510,regulation of BMP signaling pathway, 1/19,118/18614,0.113867703,0.156963026,0.086736073,SFRP1,1
GO:0002718,regulation of cytokine production involved in immune response, 1/19,119/18614,0.114777981,0.15786739,0.087235815,DDX21,1
GO:0046632,alpha-beta T cell differentiation, 1/19,119/18614,0.114777981,0.15786739,0.087235815,RUNX1,1
GO:0032355,response to estradiol, 1/19,120/18614,0.115687374,0.15876654,0.087732676,SFRP1,1
GO:0071774,response to fibroblast growth factor, 1/19,120/18614,0.115687374,0.15876654,0.087732676,SFRP1,1
GO:0002367,cytokine production involved in immune response, 1/19,121/18614,0.116595882,0.159660513,0.088226675,DDX21,1
GO:2000278,regulation of DNA biosynthetic process, 1/19,121/18614,0.116595882,0.159660513,0.088226675,HNRNPU,1
GO:0046660,female sex differentiation, 1/19,122/18614,0.117503505,0.16072616,0.08881554,SFRP1,1
GO:0022612,gland morphogenesis, 1/19,123/18614,0.118410245,0.161433067,0.08920617,SFRP1,1
GO:0042471,ear morphogenesis, 1/19,123/18614,0.118410245,0.161433067,0.08920617,RPL38,1
GO:0071901,negative regulation of protein serine/threonine kinase activity, 1/19,123/18614,0.118410245,0.161433067,0.08920617,SFRP1,1
GO:0022904,respiratory electron transport chain, 1/19,124/18614,0.119316102,0.162489692,0.089790049,MYBBP1A,1
GO:0001952,regulation of cell-matrix adhesion, 1/19,125/18614,0.120221077,0.163185331,0.090174452,SFRP1,1
GO:0002832,negative regulation of response to biotic stimulus, 1/19,125/18614,0.120221077,0.163185331,0.090174452,ADAR,1
GO:0010811,positive regulation of cell-substrate adhesion, 1/19,125/18614,0.120221077,0.163185331,0.090174452,SFRP1,1
GO:0003206,cardiac chamber morphogenesis, 1/19,126/18614,0.121125172,0.163875232,0.090555684,HIF1A,1
GO:0003231,cardiac ventricle development, 1/19,126/18614,0.121125172,0.163875232,0.090555684,HIF1A,1
GO:0021987,cerebral cortex development, 1/19,126/18614,0.121125172,0.163875232,0.090555684,HIF1A,1
GO:0035601,protein deacylation, 1/19,127/18614,0.122028386,0.164380971,0.09083515,SIRT7,1
GO:0048593,camera-type eye morphogenesis, 1/19,127/18614,0.122028386,0.164380971,0.09083515,HIF1A,1
GO:0055007,cardiac muscle cell differentiation, 1/19,127/18614,0.122028386,0.164380971,0.09083515,HNRNPU,1
GO:0090288,negative regulation of cellular response to growth factor stimulus, 1/19,127/18614,0.122028386,0.164380971,0.09083515,SFRP1,1
GO:0007127,meiosis I, 1/19,129/18614,0.123832176,0.166269798,0.091878895,SIRT7,1
GO:0007368,determination of left/right symmetry, 1/19,129/18614,0.123832176,0.166269798,0.091878895,HIF1A,1
GO:2000027,regulation of animal organ morphogenesis, 1/19,129/18614,0.123832176,0.166269798,0.091878895,SFRP1,1
GO:0007052,mitotic spindle organization, 1/19,130/18614,0.124732755,0.166757892,0.09214861,HNRNPU,1
GO:0045621,positive regulation of lymphocyte differentiation, 1/19,130/18614,0.124732755,0.166757892,0.09214861,RUNX1,1
GO:0045739,positive regulation of DNA repair, 1/19,130/18614,0.124732755,0.166757892,0.09214861,DHX9,1
GO:0050864,regulation of B cell activation, 1/19,130/18614,0.124732755,0.166757892,0.09214861,SFRP1,1
GO:0010595,positive regulation of endothelial cell migration, 1/19,131/18614,0.125632456,0.167061574,0.092316422,HIF1A,1
GO:0050868,negative regulation of T cell activation, 1/19,131/18614,0.125632456,0.167061574,0.092316422,RUNX1,1
GO:0051225,spindle assembly, 1/19,131/18614,0.125632456,0.167061574,0.092316422,HNRNPU,1
GO:0051983,regulation of chromosome segregation, 1/19,131/18614,0.125632456,0.167061574,0.092316422,HNRNPU,1
GO:0098732,macromolecule deacylation, 1/19,131/18614,0.125632456,0.167061574,0.092316422,SIRT7,1
GO:0016571,histone methylation, 1/19,133/18614,0.127429231,0.169088787,0.093436638,FBL,1
GO:2000779,regulation of double-strand break repair, 1/19,133/18614,0.127429231,0.169088787,0.093436638,SIRT7,1
GO:0000018,regulation of DNA recombination, 1/19,134/18614,0.128326306,0.169194556,0.093495085,ALYREF,1
GO:0002702,positive regulation of production of molecular mediator of immune response, 1/19,134/18614,0.128326306,0.169194556,0.093495085,DDX21,1
GO:0009132,nucleoside diphosphate metabolic process, 1/19,134/18614,0.128326306,0.169194556,0.093495085,HIF1A,1
GO:0051224,negative regulation of protein transport, 1/19,134/18614,0.128326306,0.169194556,0.093495085,SFRP1,1
GO:0060972,left/right pattern formation, 1/19,134/18614,0.128326306,0.169194556,0.093495085,HIF1A,1
GO:0061982,meiosis I cell cycle process, 1/19,134/18614,0.128326306,0.169194556,0.093495085,SIRT7,1
GO:0042476,odontogenesis, 1/19,135/18614,0.129222507,0.169835295,0.09384915,AXIN2,1
GO:0043401,steroid hormone mediated signaling pathway, 1/19,135/18614,0.129222507,0.169835295,0.09384915,SFRP1,1
GO:0043467,regulation of generation of precursor metabolites and energy, 1/19,135/18614,0.129222507,0.169835295,0.09384915,HIF1A,1
GO:0030879,mammary gland development, 1/19,136/18614,0.130117835,0.170650846,0.094299815,HIF1A,1
GO:0071333,cellular response to glucose stimulus, 1/19,136/18614,0.130117835,0.170650846,0.094299815,HIF1A,1
GO:0007498,mesoderm development, 1/19,137/18614,0.131012291,0.171281333,0.094648215,RPL38,1
GO:0031929,TOR signaling, 1/19,137/18614,0.131012291,0.171281333,0.094648215,HIF1A,1
GO:1903052,positive regulation of proteolysis involved in protein catabolic process, 1/19,137/18614,0.131012291,0.171281333,0.094648215,AXIN2,1
GO:0046887,positive regulation of hormone secretion, 1/19,138/18614,0.131905876,0.171906714,0.094993794,HIF1A,1
GO:0071331,cellular response to hexose stimulus, 1/19,138/18614,0.131905876,0.171906714,0.094993794,HIF1A,1
GO:1904950,negative regulation of establishment of protein localization, 1/19,138/18614,0.131905876,0.171906714,0.094993794,SFRP1,1
GO:0009855,determination of bilateral symmetry, 1/19,139/18614,0.132798591,0.172707696,0.095436408,HIF1A,1
GO:0046328,regulation of JNK cascade, 1/19,139/18614,0.132798591,0.172707696,0.095436408,SFRP1,1
GO:0009799,specification of symmetry, 1/19,140/18614,0.133690435,0.172962,0.095576934,HIF1A,1
GO:0071326,cellular response to monosaccharide stimulus, 1/19,140/18614,0.133690435,0.172962,0.095576934,HIF1A,1
GO:1903008,organelle disassembly, 1/19,140/18614,0.133690435,0.172962,0.095576934,HIF1A,1
GO:1904019,epithelial cell apoptotic process, 1/19,140/18614,0.133690435,0.172962,0.095576934,ADAR,1
GO:2001235,positive regulation of apoptotic signaling pathway, 1/19,140/18614,0.133690435,0.172962,0.095576934,SFRP1,1
GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process, 1/19,141/18614,0.134581411,0.173933519,0.096113785,AXIN2,1
GO:0010212,response to ionizing radiation, 1/19,143/18614,0.136360758,0.17604996,0.097283307,SFRP1,1
GO:0008584,male gonad development, 1/19,144/18614,0.137249131,0.177012898,0.097815416,SFRP1,1
GO:0046546,development of primary male sexual characteristics, 1/19,145/18614,0.138136639,0.177972724,0.098345805,SFRP1,1
GO:0007224,smoothened signaling pathway, 1/19,146/18614,0.139023282,0.17800713,0.098364818,SFRP1,1
GO:0010508,positive regulation of autophagy, 1/19,146/18614,0.139023282,0.17800713,0.098364818,HIF1A,1
GO:0030177,positive regulation of Wnt signaling pathway, 1/19,146/18614,0.139023282,0.17800713,0.098364818,SFRP1,1
GO:0050714,positive regulation of protein secretion, 1/19,146/18614,0.139023282,0.17800713,0.098364818,HIF1A,1
GO:0062013,positive regulation of small molecule metabolic process, 1/19,146/18614,0.139023282,0.17800713,0.098364818,HIF1A,1
GO:0072073,kidney epithelium development, 1/19,146/18614,0.139023282,0.17800713,0.098364818,SFRP1,1
GO:0002705,positive regulation of leukocyte mediated immunity, 1/19,148/18614,0.140793975,0.180088689,0.099515065,DDX21,1
GO:0061351,neural precursor cell proliferation, 1/19,150/18614,0.142561219,0.181787509,0.100453814,HIF1A,1
GO:1903038,negative regulation of leukocyte cell-cell adhesion, 1/19,150/18614,0.142561219,0.181787509,0.100453814,RUNX1,1
GO:2000377,regulation of reactive oxygen species metabolic process, 1/19,150/18614,0.142561219,0.181787509,0.100453814,HIF1A,1
GO:0001890,placenta development, 1/19,152/18614,0.144325018,0.183283918,0.101280714,HIF1A,1
GO:0007612,learning, 1/19,152/18614,0.144325018,0.183283918,0.101280714,HIF1A,1
GO:0043535,regulation of blood vessel endothelial cell migration, 1/19,152/18614,0.144325018,0.183283918,0.101280714,HIF1A,1
GO:0071322,cellular response to carbohydrate stimulus, 1/19,152/18614,0.144325018,0.183283918,0.101280714,HIF1A,1
GO:0030183,B cell differentiation, 1/19,153/18614,0.145205628,0.184025908,0.10169073,SFRP1,1
GO:0046718,viral entry into host cell, 1/19,153/18614,0.145205628,0.184025908,0.10169073,IFITM1,1
GO:0050729,positive regulation of inflammatory response, 1/19,154/18614,0.14608538,0.184952132,0.102202551,DHX9,1
GO:0043524,negative regulation of neuron apoptotic process, 1/19,155/18614,0.146964273,0.185497589,0.102503965,HIF1A,1
GO:0060041,retina development in camera-type eye, 1/19,155/18614,0.146964273,0.185497589,0.102503965,HIF1A,1
GO:0070507,regulation of microtubule cytoskeleton organization, 1/19,155/18614,0.146964273,0.185497589,0.102503965,HNRNPU,1
GO:0000723,telomere maintenance, 1/19,156/18614,0.14784231,0.185662436,0.102595057,HNRNPU,1
GO:0007584,response to nutrient, 1/19,156/18614,0.14784231,0.185662436,0.102595057,SFRP1,1
GO:0007605,sensory perception of sound, 1/19,156/18614,0.14784231,0.185662436,0.102595057,RPL38,1
GO:1903531,negative regulation of secretion by cell, 1/19,156/18614,0.14784231,0.185662436,0.102595057,SFRP1,1
GO:2001236,regulation of extrinsic apoptotic signaling pathway, 1/19,156/18614,0.14784231,0.185662436,0.102595057,SFRP1,1
GO:0001678,intracellular glucose homeostasis, 1/19,157/18614,0.14871949,0.186387091,0.102995494,HIF1A,1
GO:0048592,eye morphogenesis, 1/19,157/18614,0.14871949,0.186387091,0.102995494,HIF1A,1
GO:0016241,regulation of macroautophagy, 1/19,159/18614,0.150471286,0.188202756,0.103998811,HIF1A,1
GO:0051092,positive regulation of NF-kappaB transcription factor activity, 1/19,159/18614,0.150471286,0.188202756,0.103998811,DHX9,1
GO:0006261,DNA-templated DNA replication, 1/19,160/18614,0.151345902,0.188916191,0.104393047,ALYREF,1
GO:0044409,entry into host, 1/19,160/18614,0.151345902,0.188916191,0.104393047,IFITM1,1
GO:0035051,cardiocyte differentiation, 1/19,161/18614,0.152219665,0.18924607,0.104575335,HNRNPU,1
GO:0051017,actin filament bundle assembly, 1/19,161/18614,0.152219665,0.18924607,0.104575335,SFRP1,1
GO:1902850,microtubule cytoskeleton organization involved in mitosis, 1/19,161/18614,0.152219665,0.18924607,0.104575335,HNRNPU,1
GO:1990845,adaptive thermogenesis, 1/19,161/18614,0.152219665,0.18924607,0.104575335,HNRNPU,1
GO:0016052,carbohydrate catabolic process, 1/19,162/18614,0.153092576,0.19014098,0.105069852,HIF1A,1
GO:0051100,negative regulation of binding, 1/19,163/18614,0.153964636,0.191033045,0.105562798,GTPBP4,1
GO:0030307,positive regulation of cell growth, 1/19,164/18614,0.154835844,0.191922274,0.106054176,SFRP1,1
GO:0061572,actin filament bundle organization, 1/19,165/18614,0.155706203,0.192808678,0.106543994,SFRP1,1
GO:0003205,cardiac chamber development, 1/19,166/18614,0.156575713,0.193692266,0.107032255,HIF1A,1
GO:2001022,positive regulation of response to DNA damage stimulus, 1/19,167/18614,0.157444374,0.194573047,0.107518965,DHX9,1
GO:0046661,male sex differentiation, 1/19,168/18614,0.158312188,0.195451031,0.108004129,SFRP1,1
GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway, 1/19,169/18614,0.159179154,0.196326226,0.108487753,SFRP1,1
GO:0007254,JNK cascade, 1/19,170/18614,0.160045275,0.197198642,0.108969841,SFRP1,1
GO:1902905,positive regulation of supramolecular fiber organization, 1/19,171/18614,0.16091055,0.198068289,0.109450398,SFRP1,1
GO:0072331,signal transduction by p53 class mediator, 1/19,173/18614,0.162638569,0.19960188,0.110297843,MYBBP1A,1
GO:2000058,regulation of ubiquitin-dependent protein catabolic process, 1/19,173/18614,0.162638569,0.19960188,0.110297843,AXIN2,1
GO:2001242,regulation of intrinsic apoptotic signaling pathway, 1/19,173/18614,0.162638569,0.19960188,0.110297843,HIF1A,1
GO:0046631,alpha-beta T cell activation, 1/19,175/18614,0.164363215,0.201519361,0.111357423,RUNX1,1
GO:0010634,positive regulation of epithelial cell migration, 1/19,176/18614,0.165224276,0.201778319,0.11150052,HIF1A,1
GO:0030509,BMP signaling pathway, 1/19,176/18614,0.165224276,0.201778319,0.11150052,SFRP1,1
GO:0048660,regulation of smooth muscle cell proliferation, 1/19,176/18614,0.165224276,0.201778319,0.11150052,IGFBP3,1
GO:0051099,positive regulation of binding, 1/19,176/18614,0.165224276,0.201778319,0.11150052,DHX9,1
GO:0010469,regulation of signaling receptor activity, 1/19,177/18614,0.166084496,0.202034225,0.111641931,HIF1A,1
GO:0019827,stem cell population maintenance, 1/19,177/18614,0.166084496,0.202034225,0.111641931,SFRP1,1
GO:0022900,electron transport chain, 1/19,177/18614,0.166084496,0.202034225,0.111641931,MYBBP1A,1
GO:0050680,negative regulation of epithelial cell proliferation, 1/19,177/18614,0.166084496,0.202034225,0.111641931,SFRP1,1
GO:0032635,interleukin-6 production, 1/19,178/18614,0.166943876,0.202682594,0.112000213,DHX9,1
GO:0032675,regulation of interleukin-6 production, 1/19,178/18614,0.166943876,0.202682594,0.112000213,DHX9,1
GO:0043534,blood vessel endothelial cell migration, 1/19,179/18614,0.167802417,0.203327417,0.112356535,HIF1A,1
GO:0050954,sensory perception of mechanical stimulus, 1/19,179/18614,0.167802417,0.203327417,0.112356535,RPL38,1
GO:0035265,organ growth, 1/19,180/18614,0.16866012,0.203572273,0.11249184,RUNX1,1
GO:0045580,regulation of T cell differentiation, 1/19,180/18614,0.16866012,0.203572273,0.11249184,RUNX1,1
GO:0048659,smooth muscle cell proliferation, 1/19,180/18614,0.16866012,0.203572273,0.11249184,IGFBP3,1
GO:0051048,negative regulation of secretion, 1/19,180/18614,0.16866012,0.203572273,0.11249184,SFRP1,1
GO:0098727,maintenance of cell number, 1/19,181/18614,0.169516986,0.20440786,0.112953577,SFRP1,1
GO:0006479,protein methylation, 1/19,182/18614,0.170373014,0.205041942,0.113303963,FBL,1
GO:0008213,protein alkylation, 1/19,182/18614,0.170373014,0.205041942,0.113303963,FBL,1
GO:0031503,protein-containing complex localization, 1/19,183/18614,0.171228207,0.205672566,0.113652439,HNRNPU,1
GO:0043409,negative regulation of MAPK cascade, 1/19,183/18614,0.171228207,0.205672566,0.113652439,SFRP1,1
GO:0021543,pallium development, 1/19,184/18614,0.172082565,0.20590226,0.113779365,HIF1A,1
GO:0048469,cell maturation, 1/19,184/18614,0.172082565,0.20590226,0.113779365,HIF1A,1
GO:1902107,positive regulation of leukocyte differentiation, 1/19,184/18614,0.172082565,0.20590226,0.113779365,RUNX1,1
GO:1903708,positive regulation of hemopoiesis, 1/19,184/18614,0.172082565,0.20590226,0.113779365,RUNX1,1
GO:0001936,regulation of endothelial cell proliferation, 1/19,185/18614,0.172936088,0.206129195,0.113904767,HIF1A,1
GO:0032640,tumor necrosis factor production, 1/19,185/18614,0.172936088,0.206129195,0.113904767,DHX9,1
GO:0032680,regulation of tumor necrosis factor production, 1/19,185/18614,0.172936088,0.206129195,0.113904767,DHX9,1
GO:0044000,movement in host, 1/19,185/18614,0.172936088,0.206129195,0.113904767,IFITM1,1
GO:0043405,regulation of MAP kinase activity, 1/19,186/18614,0.173788777,0.206946943,0.114356646,SFRP1,1
GO:0032200,telomere organization, 1/19,187/18614,0.174640634,0.207364883,0.114587595,HNRNPU,1
GO:0071772,response to BMP, 1/19,187/18614,0.174640634,0.207364883,0.114587595,SFRP1,1
GO:0071773,cellular response to BMP stimulus, 1/19,187/18614,0.174640634,0.207364883,0.114587595,SFRP1,1
GO:0040029,epigenetic regulation of gene expression, 1/19,188/18614,0.175491658,0.20797771,0.114926237,HNRNPU,1
GO:0061138,morphogenesis of a branching epithelium, 1/19,188/18614,0.175491658,0.20797771,0.114926237,SFRP1,1
GO:0002700,regulation of production of molecular mediator of immune response, 1/19,189/18614,0.176341852,0.208786063,0.115372924,DDX21,1
GO:0031099,regeneration, 1/19,190/18614,0.177191214,0.208994765,0.115488251,RUNX1,1
GO:0051495,positive regulation of cytoskeleton organization, 1/19,190/18614,0.177191214,0.208994765,0.115488251,SFRP1,1
GO:0071706,tumor necrosis factor superfamily cytokine production, 1/19,190/18614,0.177191214,0.208994765,0.115488251,DHX9,1
GO:1903555,regulation of tumor necrosis factor superfamily cytokine production, 1/19,190/18614,0.177191214,0.208994765,0.115488251,DHX9,1
GO:0030308,negative regulation of cell growth, 1/19,191/18614,0.178039747,0.209200913,0.115602166,SFRP1,1
GO:0050777,negative regulation of immune response, 1/19,191/18614,0.178039747,0.209200913,0.115602166,ADAR,1
GO:0051260,protein homooligomerization, 1/19,191/18614,0.178039747,0.209200913,0.115602166,RBMX,1
GO:0071478,cellular response to radiation, 1/19,191/18614,0.178039747,0.209200913,0.115602166,SFRP1,1
GO:0009755,hormone-mediated signaling pathway, 1/19,192/18614,0.17888745,0.209602088,0.115823851,SFRP1,1
GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling, 1/19,192/18614,0.17888745,0.209602088,0.115823851,DDX21,1
GO:0055001,muscle cell development, 1/19,192/18614,0.17888745,0.209602088,0.115823851,HNRNPU,1
GO:0032872,regulation of stress-activated MAPK cascade, 1/19,193/18614,0.179734326,0.210395884,0.116262494,SFRP1,1
GO:0009749,response to glucose, 1/19,194/18614,0.180580374,0.210790248,0.116480415,HIF1A,1
GO:0045664,regulation of neuron differentiation, 1/19,194/18614,0.180580374,0.210790248,0.116480415,SFRP1,1
GO:0061136,regulation of proteasomal protein catabolic process, 1/19,194/18614,0.180580374,0.210790248,0.116480415,AXIN2,1
GO:0007369,gastrulation, 1/19,196/18614,0.18226999,0.211965663,0.117129936,SFRP1,1
GO:0009060,aerobic respiration, 1/19,196/18614,0.18226999,0.211965663,0.117129936,HIF1A,1
GO:0070302,regulation of stress-activated protein kinase signaling cascade, 1/19,196/18614,0.18226999,0.211965663,0.117129936,SFRP1,1
GO:0140013,meiotic nuclear division, 1/19,196/18614,0.18226999,0.211965663,0.117129936,SIRT7,1
GO:0002520,immune system development, 1/19,197/18614,0.18311356,0.212548637,0.117452082,ADAR,1
GO:0032388,positive regulation of intracellular transport, 1/19,197/18614,0.18311356,0.212548637,0.117452082,DHX9,1
GO:0007051,spindle organization, 1/19,198/18614,0.183956305,0.213128481,0.117772497,HNRNPU,1
GO:0071897,DNA biosynthetic process, 1/19,198/18614,0.183956305,0.213128481,0.117772497,HNRNPU,1
GO:0000070,mitotic sister chromatid segregation, 1/19,199/18614,0.184798227,0.213705212,0.118091193,HNRNPU,1
GO:0009746,response to hexose, 1/19,199/18614,0.184798227,0.213705212,0.118091193,HIF1A,1
GO:0001935,endothelial cell proliferation, 1/19,201/18614,0.186479602,0.215448992,0.119054787,HIF1A,1
GO:0031032,actomyosin structure organization, 1/19,202/18614,0.187319057,0.216217722,0.119479579,SFRP1,1
GO:0001763,morphogenesis of a branching structure, 1/19,203/18614,0.188157692,0.216984079,0.119903059,SFRP1,1
GO:0000302,response to reactive oxygen species, 1/19,205/18614,0.189832502,0.2187124,0.120858111,HIF1A,1
GO:2000241,regulation of reproductive process, 1/19,206/18614,0.190668679,0.219472196,0.121277966,SFRP1,1
GO:0034284,response to monosaccharide, 1/19,207/18614,0.191504038,0.220025916,0.121583946,HIF1A,1
GO:1902115,regulation of organelle assembly, 1/19,207/18614,0.191504038,0.220025916,0.121583946,HNRNPU,1
GO:0045732,positive regulation of protein catabolic process, 1/19,209/18614,0.193172307,0.221737528,0.122529764,AXIN2,1
GO:0002064,epithelial cell development, 1/19,210/18614,0.194005218,0.222282731,0.122831037,HIF1A,1
GO:1903828,negative regulation of protein localization, 1/19,210/18614,0.194005218,0.222282731,0.122831037,SFRP1,1
GO:0050821,protein stabilization, 1/19,213/18614,0.196499066,0.224932572,0.12429531,GTPBP4,1
GO:0016051,carbohydrate biosynthetic process, 1/19,214/18614,0.197328723,0.225466674,0.124590449,SIRT7,1
GO:1901888,regulation of cell junction assembly, 1/19,214/18614,0.197328723,0.225466674,0.124590449,SFRP1,1
GO:1903046,meiotic cell cycle process, 1/19,215/18614,0.198157568,0.226205607,0.124998776,SIRT7,1
GO:0043523,regulation of neuron apoptotic process, 1/19,219/18614,0.201464849,0.229348618,0.12673557,HIF1A,1
GO:0046034,ATP metabolic process, 1/19,219/18614,0.201464849,0.229348618,0.12673557,HIF1A,1
GO:1901215,negative regulation of neuron death, 1/19,219/18614,0.201464849,0.229348618,0.12673557,HIF1A,1
GO:0043583,ear development, 1/19,221/18614,0.203113638,0.231013863,0.127655767,RPL38,1
GO:0010810,regulation of cell-substrate adhesion, 1/19,222/18614,0.203936823,0.231737909,0.128055866,SFRP1,1
GO:0033157,regulation of intracellular protein transport, 1/19,224/18614,0.205580777,0.233392436,0.12897014,SIRT7,1
GO:0097191,extrinsic apoptotic signaling pathway, 1/19,227/18614,0.208040678,0.235969427,0.130394157,SFRP1,1
GO:0008406,gonad development, 1/19,228/18614,0.208859041,0.236681504,0.130787644,SFRP1,1
GO:1903050,regulation of proteolysis involved in protein catabolic process, 1/19,230/18614,0.210493362,0.238316095,0.131690901,AXIN2,1
GO:0010594,regulation of endothelial cell migration, 1/19,232/18614,0.212124485,0.239725761,0.132469867,HIF1A,1
GO:0050769,positive regulation of neurogenesis, 1/19,232/18614,0.212124485,0.239725761,0.132469867,HIF1A,1
GO:0045137,development of primary sexual characteristics, 1/19,233/18614,0.212938849,0.239990972,0.13261642,SFRP1,1
GO:0051651,maintenance of location in cell, 1/19,233/18614,0.212938849,0.239990972,0.13261642,HNRNPU,1
GO:2001234,negative regulation of apoptotic signaling pathway, 1/19,233/18614,0.212938849,0.239990972,0.13261642,HIF1A,1
GO:0009743,response to carbohydrate, 1/19,234/18614,0.213752415,0.240471467,0.132881936,HIF1A,1
GO:0060560,developmental growth involved in morphogenesis, 1/19,234/18614,0.213752415,0.240471467,0.132881936,SFRP1,1
GO:0060348,bone development, 1/19,235/18614,0.214565185,0.241167384,0.133266493,AXIN2,1
GO:0051403,stress-activated MAPK cascade, 1/19,237/18614,0.216188337,0.242552768,0.134032041,SFRP1,1
GO:0072593,reactive oxygen species metabolic process, 1/19,237/18614,0.216188337,0.242552768,0.134032041,HIF1A,1
GO:0007160,cell-matrix adhesion, 1/19,239/18614,0.21780831,0.244149749,0.134914515,SFRP1,1
GO:0042445,hormone metabolic process, 1/19,241/18614,0.219425112,0.245740296,0.135793434,HIF1A,1
GO:0009205,purine ribonucleoside triphosphate metabolic process, 1/19,244/18614,0.221844379,0.248225872,0.137166937,HIF1A,1
GO:0031098,stress-activated protein kinase signaling cascade, 1/19,245/18614,0.222649221,0.24890219,0.137540662,SFRP1,1
GO:0002703,regulation of leukocyte mediated immunity, 1/19,246/18614,0.223453275,0.24957641,0.137913229,DDX21,1
GO:0071695,anatomical structure maturation, 1/19,247/18614,0.224256541,0.250248539,0.138284641,HIF1A,1
GO:0042593,glucose homeostasis, 1/19,248/18614,0.22505902,0.250693545,0.138530546,HIF1A,1
GO:0051259,protein complex oligomerization, 1/19,248/18614,0.22505902,0.250693545,0.138530546,RBMX,1
GO:0009144,purine nucleoside triphosphate metabolic process, 1/19,249/18614,0.225860712,0.250911453,0.138650959,HIF1A,1
GO:0033500,carbohydrate homeostasis, 1/19,249/18614,0.225860712,0.250911453,0.138650959,HIF1A,1
GO:0050870,positive regulation of T cell activation, 1/19,249/18614,0.225860712,0.250911453,0.138650959,RUNX1,1
GO:0000819,sister chromatid segregation, 1/19,250/18614,0.226661618,0.251351544,0.138894149,HNRNPU,1
GO:0016485,protein processing, 1/19,250/18614,0.226661618,0.251351544,0.138894149,RUNX1,1
GO:0009199,ribonucleoside triphosphate metabolic process, 1/19,251/18614,0.22746174,0.25201381,0.13926011,HIF1A,1
GO:0032886,regulation of microtubule-based process, 1/19,252/18614,0.228261077,0.252449027,0.139500606,HNRNPU,1
GO:0097305,response to alcohol, 1/19,252/18614,0.228261077,0.252449027,0.139500606,SFRP1,1
GO:0050730,regulation of peptidyl-tyrosine phosphorylation, 1/19,255/18614,0.230654389,0.254868996,0.140837855,SFRP1,1
GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling, 1/19,258/18614,0.233040669,0.257048411,0.142042177,DDX21,1
GO:0045927,positive regulation of growth, 1/19,258/18614,0.233040669,0.257048411,0.142042177,SFRP1,1
GO:0051402,neuron apoptotic process, 1/19,259/18614,0.233834537,0.257695204,0.142399587,HIF1A,1
GO:0090068,positive regulation of cell cycle process, 1/19,262/18614,0.23621147,0.260083906,0.143719558,HNRNPU,1
GO:0002699,positive regulation of immune effector process, 1/19,267/18614,0.240157509,0.264194531,0.145991045,DDX21,1
GO:0110053,regulation of actin filament organization, 1/19,268/18614,0.240944395,0.26482561,0.146339772,SFRP1,1
GO:0009141,nucleoside triphosphate metabolic process, 1/19,269/18614,0.24173051,0.265454724,0.146687414,HIF1A,1
GO:0021537,telencephalon development, 1/19,270/18614,0.242515853,0.266081881,0.147033974,HIF1A,1
GO:0051091,positive regulation of DNA-binding transcription factor activity, 1/19,271/18614,0.243300425,0.266707086,0.147379456,DHX9,1
GO:0043547,positive regulation of GTPase activity, 1/19,272/18614,0.244084228,0.267330345,0.147723862,SFRP1,1
GO:1903039,positive regulation of leukocyte cell-cell adhesion, 1/19,273/18614,0.244867261,0.267951664,0.148067196,RUNX1,1
GO:0071560,cellular response to transforming growth factor beta stimulus, 1/19,274/18614,0.245649526,0.268571049,0.148409462,SFRP1,1
GO:0007611,learning or memory, 1/19,276/18614,0.247211754,0.269804041,0.1490908,HIF1A,1
GO:0042113,B cell activation, 1/19,276/18614,0.247211754,0.269804041,0.1490908,SFRP1,1
GO:0051962,positive regulation of nervous system development, 1/19,280/18614,0.250327018,0.272724699,0.150704724,HIF1A,1
GO:0071559,response to transforming growth factor beta, 1/19,280/18614,0.250327018,0.272724699,0.150704724,SFRP1,1
GO:0045165,cell fate commitment, 1/19,281/18614,0.251103924,0.273331353,0.151039954,SFRP1,1
GO:0007548,sex differentiation, 1/19,283/18614,0.252655447,0.27453899,0.151707281,SFRP1,1
GO:0043542,endothelial cell migration, 1/19,283/18614,0.252655447,0.27453899,0.151707281,HIF1A,1
GO:0031348,negative regulation of defense response, 1/19,284/18614,0.253430067,0.274899688,0.151906599,ADAR,1
GO:0051321,meiotic cell cycle, 1/19,284/18614,0.253430067,0.274899688,0.151906599,SIRT7,1
GO:1903532,positive regulation of secretion by cell, 1/19,289/18614,0.257291767,0.278845004,0.154086738,HIF1A,1
GO:0034599,cellular response to oxidative stress, 1/19,290/18614,0.258061833,0.279435742,0.154413174,HIF1A,1
GO:0007249,I-kappaB kinase/NF-kappaB signaling, 1/19,293/18614,0.260367495,0.281686784,0.155657075,DDX21,1
GO:0010632,regulation of epithelial cell migration, 1/19,295/18614,0.261900829,0.283099069,0.156437489,HIF1A,1
GO:0051146,striated muscle cell differentiation, 1/19,297/18614,0.263431152,0.284505645,0.157214747,HNRNPU,1
GO:0030522,intracellular receptor signaling pathway, 1/19,299/18614,0.264958469,0.285906532,0.157988863,SFRP1,1
GO:0030217,T cell differentiation, 1/19,300/18614,0.265721002,0.28623199,0.158168707,RUNX1,1
GO:0045089,positive regulation of innate immune response, 1/19,300/18614,0.265721002,0.28623199,0.158168707,DHX9,1
GO:0048608,reproductive structure development, 1/19,301/18614,0.266482786,0.286555515,0.158347483,SFRP1,1
GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway, 1/19,301/18614,0.266482786,0.286555515,0.158347483,SFRP1,1
GO:0006302,double-strand break repair, 1/19,303/18614,0.268004107,0.287693259,0.158976188,SIRT7,1
GO:0051054,positive regulation of DNA metabolic process, 1/19,303/18614,0.268004107,0.287693259,0.158976188,DHX9,1
GO:0034504,protein localization to nucleus, 1/19,304/18614,0.268763646,0.288259454,0.159289062,HNRNPU,1
GO:0061458,reproductive system development, 1/19,305/18614,0.269522438,0.288823873,0.159600953,SFRP1,1
GO:0051222,positive regulation of protein transport, 1/19,309/18614,0.272550155,0.291816632,0.16125472,HIF1A,1
GO:0001822,kidney development, 1/19,310/18614,0.273305225,0.292373031,0.16156218,SFRP1,1
GO:0050890,cognition, 1/19,317/18614,0.278569959,0.297492596,0.164391196,HIF1A,1
GO:0051047,positive regulation of secretion, 1/19,317/18614,0.278569959,0.297492596,0.164391196,HIF1A,1
GO:0021700,developmental maturation, 1/19,319/18614,0.280067519,0.29883493,0.165132956,HIF1A,1
GO:0043414,macromolecule methylation, 1/19,320/18614,0.280815194,0.299118758,0.165289796,FBL,1
GO:0072001,renal system development, 1/19,320/18614,0.280815194,0.299118758,0.165289796,SFRP1,1
GO:0022409,positive regulation of cell-cell adhesion, 1/19,321/18614,0.281562134,0.299657387,0.165587436,RUNX1,1
GO:0016236,macroautophagy, 1/19,322/18614,0.282308338,0.299937516,0.165742233,HIF1A,1
GO:0031647,regulation of protein stability, 1/19,322/18614,0.282308338,0.299937516,0.165742233,GTPBP4,1
GO:0009416,response to light stimulus, 1/19,323/18614,0.283053809,0.300472505,0.166037862,HIF1A,1
GO:1904951,positive regulation of establishment of protein localization, 1/19,325/18614,0.284542549,0.301794915,0.166768612,HIF1A,1
GO:0002833,positive regulation of response to biotic stimulus, 1/19,327/18614,0.28602836,0.302595591,0.167211056,DHX9,1
GO:0051251,positive regulation of lymphocyte activation, 1/19,327/18614,0.28602836,0.302595591,0.167211056,RUNX1,1
GO:1901214,regulation of neuron death, 1/19,327/18614,0.28602836,0.302595591,0.167211056,HIF1A,1
GO:0002440,production of molecular mediator of immune response, 1/19,328/18614,0.286770169,0.302864413,0.167359605,DDX21,1
GO:0048638,regulation of developmental growth, 1/19,328/18614,0.286770169,0.302864413,0.167359605,RUNX1,1
GO:0006310,DNA recombination, 1/19,332/18614,0.28973011,0.305470965,0.168799957,ALYREF,1
GO:0051604,protein maturation, 1/19,332/18614,0.28973011,0.305470965,0.168799957,RUNX1,1
GO:0043010,camera-type eye development, 1/19,338/18614,0.29414821,0.309866053,0.171228635,HIF1A,1
GO:0071214,cellular response to abiotic stimulus, 1/19,339/18614,0.294882024,0.310113017,0.171365105,SFRP1,1
GO:0104004,cellular response to environmental stimulus, 1/19,339/18614,0.294882024,0.310113017,0.171365105,SFRP1,1
GO:0032956,regulation of actin cytoskeleton organization, 1/19,346/18614,0.299998521,0.315226873,0.174190966,SFRP1,1
GO:0051235,maintenance of location, 1/19,347/18614,0.300726572,0.31572477,0.174466099,HNRNPU,1
GO:0010506,regulation of autophagy, 1/19,348/18614,0.301453905,0.316221073,0.17474035,HIF1A,1
GO:0062197,cellular response to chemical stress, 1/19,349/18614,0.302180522,0.316715787,0.175013724,HIF1A,1
GO:0045787,positive regulation of cell cycle, 1/19,354/18614,0.305802876,0.320242135,0.176962346,HNRNPU,1
GO:0031589,cell-substrate adhesion, 1/19,359/18614,0.309407412,0.323743897,0.178897382,SFRP1,1
GO:0042176,regulation of protein catabolic process, 1/19,361/18614,0.310844255,0.324700223,0.179425837,AXIN2,1
GO:0050878,regulation of body fluid levels, 1/19,361/18614,0.310844255,0.324700223,0.179425837,HIF1A,1
GO:0010639,negative regulation of organelle organization, 1/19,362/18614,0.311561615,0.325176072,0.179688786,HNRNPU,1
GO:0043087,regulation of GTPase activity, 1/19,364/18614,0.312994211,0.326396986,0.18036345,SFRP1,1
GO:0032259,methylation, 1/19,365/18614,0.31370945,0.326594415,0.180472547,FBL,1
GO:0045862,positive regulation of proteolysis, 1/19,365/18614,0.31370945,0.326594415,0.180472547,AXIN2,1
GO:0045860,positive regulation of protein kinase activity, 1/19,366/18614,0.314423984,0.327064144,0.180732114,AXIN2,1
GO:0010038,response to metal ion, 1/19,367/18614,0.315137812,0.327532354,0.180990842,HIF1A,1
GO:0018108,peptidyl-tyrosine phosphorylation, 1/19,370/18614,0.317275076,0.329477963,0.182065965,SFRP1,1
GO:0010631,epithelial cell migration, 1/19,371/18614,0.317986092,0.329940456,0.182321533,HIF1A,1
GO:0018212,peptidyl-tyrosine modification, 1/19,372/18614,0.318696406,0.330401449,0.182576273,SFRP1,1
GO:0070997,neuron death, 1/19,373/18614,0.319406019,0.330860948,0.182830187,HIF1A,1
GO:0090132,epithelium migration, 1/19,374/18614,0.320114933,0.331318955,0.183083277,HIF1A,1
GO:1902903,regulation of supramolecular fiber organization, 1/19,376/18614,0.321530661,0.332507145,0.183739858,SFRP1,1
GO:0002696,positive regulation of leukocyte activation, 1/19,377/18614,0.322237477,0.332684079,0.18383763,RUNX1,1
GO:0050863,regulation of T cell activation, 1/19,377/18614,0.322237477,0.332684079,0.18383763,RUNX1,1
GO:1903037,regulation of leukocyte cell-cell adhesion, 1/19,378/18614,0.322943596,0.333136168,0.184087449,RUNX1,1
GO:0090130,tissue migration, 1/19,379/18614,0.323649018,0.333586789,0.184336457,HIF1A,1
GO:0050767,regulation of neurogenesis, 1/19,381/18614,0.325057773,0.33476099,0.184985309,HIF1A,1
GO:0002697,regulation of immune effector process, 1/19,384/18614,0.327165695,0.336652687,0.18603064,DDX21,1
GO:0001654,eye development, 1/19,385/18614,0.327866948,0.337094992,0.186275053,HIF1A,1
GO:0032970,regulation of actin filament-based process, 1/19,387/18614,0.329267379,0.338254826,0.186915964,SFRP1,1
GO:0150063,visual system development, 1/19,389/18614,0.330665044,0.339409905,0.187554249,HIF1A,1
GO:0050867,positive regulation of cell activation, 1/19,394/18614,0.334147147,0.342700873,0.189372802,RUNX1,1
GO:0048880,sensory system development, 1/19,395/18614,0.334841506,0.343129662,0.189609746,HIF1A,1
GO:0030900,forebrain development, 1/19,397/18614,0.336228164,0.344266595,0.190238003,HIF1A,1
GO:0001701,in utero embryonic development, 1/19,398/18614,0.336920466,0.344407588,0.190315914,HIF1A,1
GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway, 1/19,398/18614,0.336920466,0.344407588,0.190315914,SFRP1,1
GO:0002443,leukocyte mediated immunity, 1/19,401/18614,0.33899327,0.345956977,0.19117209,DDX21,1
GO:0009100,glycoprotein metabolic process, 1/19,401/18614,0.33899327,0.345956977,0.19117209,HIF1A,1
GO:0042692,muscle cell differentiation, 1/19,410/18614,0.345174913,0.351976389,0.194498352,HNRNPU,1
GO:0050727,regulation of inflammatory response, 1/19,414/18614,0.347904694,0.354468933,0.195875705,DHX9,1
GO:0007159,leukocyte cell-cell adhesion, 1/19,415/18614,0.348585453,0.35487142,0.196098115,RUNX1,1
GO:0033674,positive regulation of kinase activity, 1/19,430/18614,0.358716389,0.364885958,0.201632041,AXIN2,1
GO:0006979,response to oxidative stress, 1/19,434/18614,0.361392655,0.367307429,0.202970119,HIF1A,1
GO:0022412,cellular process involved in reproduction in multicellular organism, 1/19,438/18614,0.364058338,0.369714191,0.20430007,SFRP1,1
GO:0042060,wound healing, 1/19,439/18614,0.36472311,0.369784574,0.204338963,HIF1A,1
GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process, 1/19,439/18614,0.36472311,0.369784574,0.204338963,AXIN2,1
GO:0009410,response to xenobiotic stimulus, 1/19,440/18614,0.365387223,0.370155735,0.204544063,SFRP1,1
GO:0031349,positive regulation of defense response, 1/19,441/18614,0.366050679,0.370525626,0.20474846,DHX9,1
GO:0007015,actin filament organization, 1/19,442/18614,0.366713478,0.37089425,0.204952158,SFRP1,1
GO:0034329,cell junction assembly, 1/19,444/18614,0.368037106,0.371930094,0.205524554,SFRP1,1
GO:0009150,purine ribonucleotide metabolic process, 1/19,445/18614,0.368697936,0.372294989,0.205726191,HIF1A,1
GO:0032102,negative regulation of response to external stimulus, 1/19,446/18614,0.369358112,0.372658632,0.205927136,ADAR,1
GO:0010975,regulation of neuron projection development, 1/19,452/18614,0.373305455,0.376335532,0.207958951,SFRP1,1
GO:0051960,regulation of nervous system development, 1/19,461/18614,0.379182607,0.381950363,0.211061647,HIF1A,1
GO:0009259,ribonucleotide metabolic process, 1/19,464/18614,0.381130027,0.383600886,0.211973708,HIF1A,1
GO:0051090,regulation of DNA-binding transcription factor activity, 1/19,465/18614,0.38177788,0.383941803,0.212162095,DHX9,1
GO:0044772,mitotic cell cycle phase transition, 1/19,467/18614,0.383071658,0.384931229,0.212708841,SIRT7,1
GO:1903829,positive regulation of protein localization, 1/19,468/18614,0.383717585,0.385268586,0.212895261,HIF1A,1
GO:0019693,ribose phosphate metabolic process, 1/19,473/18614,0.386937622,0.388187824,0.2145084,HIF1A,1
GO:0051051,negative regulation of transport, 1/19,483/18614,0.393329939,0.394282312,0.217876148,SFRP1,1
GO:0022411,cellular component disassembly, 1/19,488/18614,0.396502369,0.397141889,0.219456319,HIF1A,1
GO:0043410,positive regulation of MAPK cascade, 1/19,495/18614,0.400917376,0.401240436,0.221721132,IGFBP3,1
GO:0001667,ameboidal-type cell migration, 1/19,496/18614,0.401545588,0.401545588,0.221889756,HIF1A,1